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Growth hormone receptor (GHR) is a transmembrane protein which is 
widely distributed in various tissues. The biological actions of growth 
hormone (GH) are initiated after binding of GH to GHR. The present study 
is divided into 3 parts. In the first part, the full length chicken GHR cDNA 
was amplified from the chicken brain first strand cDNA pool by a pair of 
chicken GHR specific primers. The cDNA was used as a probe in 
ontogeny study of chicken GHR mRNA expression in liver and brain. 
Chicken hepatic GHR mRNA level drastically decreased just before 
hatching. The decrease may be due to the increase in GH secretion, the 
rationale being chicken GH downregulates GHR. Chicken brain GHR 
mRNA level remained more or less constant throughout the period of the 
study. On the other hand, prokaryotic expression of chicken GHR was 
unsuccessful in the pET system used, the reason is not understood. 
The aim of the second part of the study was to clone the pigeon (Columba 
livid) GHR cDNA by PGR. The entire coding sequence of the pigeon 
GHR was obtained in 3 overlapping pieces : the main core sequence using 
chicken PGR primers, the 3'-end sequence using the random primer 
initiated RNA-PCR, and the 5'-end sequence using the AmpliFINDER 
RACE method. Our results indicated that the mature pigeon GHR 
comprises of an extracellular domain of 240 amino acids, a hydrophobic 
transmembrane domain of 24 amino acids and a cytoplasmic domain of 
I 
348 amino acids. Nucleotide sequence and predicted amino acid sequence 
of pigeon GHR bear about 90% homology to the chicken GHR. As to the 
mammalian GHRs, the homology is about 60%. 
«• I 11 
Preliminary studies on cloning of Dace GHR cDNA was performed in the 
last part. Two DNA fragments were amplified from the Dace liver first 
strand cDNA pool by two pairs of GHR conserved primers. But the 
nucleotide sequence of these two fragments only bear very low homology 
to the reported GHR cDNA sequences. Furthermore, it was found that 
either Dace total RNA or mRNA hybridized minimally with labeled 
chicken GHR cDNA probe under our washing conditions. The reason for 
these negative results might be due to the fact that fish GHR is 
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Chapter 1 Introduction 
Somatic growth is a complex phenomenon which is influenced by many 
factors, including genetic predisposition, nutrition and the interplay among 
different hormones. One of the essential hormones involved in growth and 
development is growth hormone (GH). Animals which lack GH show 
stunted growth and ones which have excessive GH display gigantism. 
1.1 A Brief Introduction of GH 
GH is a protein hormone produced in somatotrophs of the anterior 
pituitary gland. It comprises of a single polypeptide chain of about 190 
amino acids with two disulfide bridges. After synthesis it is secreted and 
transported to the target tissues through the circulatory system. Pituitary 
GH secretion is primarily regulated by the interaction of two 
hypothalamic peptides, GH releasing hormone (GHRH) and somatostatin. 
GHRH binds to specific cell surface receptors on pituitary somatotrophs 
to stimulate GH release, possibly through cAMP-dependent pathways. 
Prolonged exposure of somatotrophs to GHRH also stimulates GH 
mRNA translation and transcription. The main physiological action of 
somatostatin is to inhibit the release of GH. Somatostatin can block GH 
secretion provoked by cAMP. It may decrease ceUular permeability to 
calcium or potassium, both ions being directly involved in secretory 
processes. 
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The biological actions of GH can be divided into two categories, direct 
and indirect. Table 1.1 lists the major direct actions of GH, observable 
mainly on isolated cells and tissues. 
• Promotion of lipolysis in adipose tissue. 
• Stimulate mRNA and protein synthesis in liver e.g. oc2u globulin. 
• Stimulate insulin synthesis and secretion. 
• Stimulate glucose and amino acid uptake by muscle. 
• Retention of intracellular minerals e.g. potassium, magnesium, 
phosphate. 
• Induce differentiation of cells e.g. stimulate the conversion of 
myoblasts to myotubes in vitro. 
• Stimulate proliferation of cells and tissues e.g. chondrocytes. 
• Promote lactation 
Table 1.1. The direct actions of GH. 
In addition to the direct actions, some actions of GH are mediated by a 
secondary extracellular mediator called insulin-like growth factor I (IGF 
I). IGF-I is a protein containing 70 amino acids, produced mainly in liver 
in response to GH. The actions of GH as mediated by IGF I are called 
indirect actions (Table 1.2). 
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• Stimulate proliferation of osteoblasts. 
• Stimulate myelin formation. 
• Synergize with platelet-derived growth factor (PDGF) to promote 
fibroblast growth. 
• Act as growth factor for many cells in culture e.g. fibroblasts , 
granulosa cells. 
• Stimulate cartilage growth with glycosaminoglycan and DNA 
synthesis. 
Table 1.2. The indirect actions of GH. 
1.2 Growth Hormone Receptor (GHR) 
The biological actions of hormones are initiated by the binding to specific 
receptors on or inside cells. Hormone receptors can be divided into two 
categories (Kelly et al., 1993). The first category is known as DNA 
binding receptor. The ligands for these receptors are usually small 
molecules such as steroids or amino acid derivatives. These molecules 
pass through the cell membrane and bind to cytoplasmic or nuclear 
receptors. The hormone receptor complex in turn acts by regulating the 
level of transcription of specific target genes. The second category is 
known as membrane receptors. They are located at the cell surface. 
Hormones bind to these cell surface receptor and transduce their message 
through a second-messenger system. GHR belongs to this second 
category. 
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GH circulates in the blood partially bound to GH binding protein 
(GHBP). The remaining GH binds to transmembrane glycoprotein 
receptors called GHR which are widely distributed in various tissues, 
especially in liver. Like other protein hormones, the biological actions of 
GH is initiated after binding to the transmembrane GHR. Although it is 
known that the action of GH is initiated after binding to GHR, the post-
binding signal transduction mechanism is still unclear. 
1.2.1 Tissue Distribution of GHR 
GHR was originally thought to be restricted to the liver. However with 
the improvement in detection techniques combined with analysis of 
mRNA transcripts, the number of tissues expressing GHR has greatly 
increased (Table 1.1). 
Tissue Adipose Heart Kidney Liver Fibroblasts Lymphocytes Ovary 
Species Human Monkey""“RabbitHuman Human Human Monkey 








Pigeon 1 1 j � 
» 
Table 1.3 • Tissue distribution of GHR (adapted from Roupas & Herington，1989) 
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The highest level of expression of GHR was found in liver. In rat the 
amount of GHR mRNA transcript in liver is about twofold higher than 
that in heart and kidney (Mathews et al., 1989). For some tissues, GHR is 
not always detectable by binding assays but mRNA transcript of GHR 
can be readily identified. This may be due to the low concentration of 
GHR in these tissues or the receptor is only present in a single cell type 
out of a mixed cell population (Kelly et al., 1993). 
Although most GHRs are located on the plasma membrane of target cells, 
intracellular GHRs have been demonstrated in the cytosol of rabbit liver 
(Ymer et al” 1984). It has been suggested that they represent newly 
synthesized, spare or recently internalized receptors awaiting cycling and 
recycling to plasma membrane. 
GHR in liver 
GHR are found widely distributed in various tissues, the highest level 
being in liver (Kelly et al., 1991). The growth promoting actions of GH 
are believed to be mediated by IGF(s) which are released mainly by the 
liver in response to GH. Apart from IGF(s) induction, a number of 
enzymes such as tyrosine aminotransferase, trytophan oxygenase and 
ornithine decarboxylase which are involved with amino acid metabolism 
in the liver have been induced in response to GH (Wallis, 1988). 
Therefore GH and hepatic GHR play an important role in the growth. 
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GHR in brain 
Early findings suggested that brain is not a GH target tissue because 
radioactivity was not detected in the brain of the immature 
hypophysectomized rat injected with 125! labeled GH (Mayberry et al., 
1971). It was believed that GH could not pass through the blood brain 
barrier (Lawrence et al, 1982). Also it was found that GH- deficient 
dwarfs are intellectually normal (Pollitt & Money, 1964). Therefore it 
was believed that GH does not play any role in the brain. 
However, using monoclonal antibody to the extracellular domain of GHR, 
it was found that immimoreactive GHRs arejwidely distributed in the 
brain of several species of animals such as rabbit and rat (Lobie et al., 
1989). Also in some brain areas GHR mRNA was detected (Waters et 
al, 1990). 
In addition to GHR, Lawrence et al (1982) have demonstrated the 
presence of immunoreactive GH in rat brain and that these GH is 
synthesized in the brain itself. Moreover, Gossard et al (1987), using in 
situ hybridization have demonstrated the presence of GH mRNA in the 
rat brain. 
Several studies suggested that GH and GHR play some important roles in 
the brain. It was found that GH can stimulate ornithine, decarboxylase 
activity in brain and that this enzyme is essential in the synthesis of 
polyamines. Polyamines can stabilize polynucleic acids and ribosome 
structure, suggesting that ornithine decarboxylase is essential in the 
6 
regulation of protein synthesis and growth (Roger et al., 1974). Also it 
was found that GH added to cultured brain cells stimulates mylein 
formation (Almazan et al, 1985). It is also believed that some of the 
actions of GH in brain are mediated by IGF. It was found that IGF can 
enhance neurite outgrowth in cultured human neuroblastoma (Recio-Pinto 
& Ishii, 1984) and also regulate DNA synthesis in cultured rat 
sympathetic neuroblasts (DiCicco-Bloom & Blacky 1988). Therefore GH 
and GHR in brain are essential for the growth and development of brain. 
1.2.2 GHR Biosynthesis and Degradation 
Like other proteins, GHRs are synthesized in the rough endoplasmic 
reticulum and then transported to the Golgi apparatus where they undergo 
post-translational modification(s) such as glycosylation. The receptors are 
then packed in vesicles and transported to the membrane. They are then 
inserted into the plasma membrane by the fusion of the GHR containing 
vesicles with the plasma membrane (Roupas & Herington^ 1989). 
Cell surface GHRs turnover rapidly, Eden et al (1982) have shown that 
incubation of adipocytes with translation inhibitor, such as cycloheximide 
or puromycin for three hours, completely abolished the ability of the cells 
to bind GH. They suggested that GHRs on adipocytes undergo rapid 
turnover. Recent findings showed that the half-life of GHR is about 45 
minutes (Baxter, 1985; Gorin & Goodman^ 1985). This rapid turnover 
rate of GHR may be related to the pulsatile secretory pattern of GH. The 
receptors for hormones with pulsatile secretory patterns may require a 
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rapid turnover rate in order to recognize individual pulses and to allow 
individual pulse-related responses to occur. 
The precise mechanism of GHR internalization is still unclear but it is 
believed that internalization is through cell surface redistribution and 
aggregation into patches following binding of GH (Eshet et al” 1984). 
About 75% of internalized GHR is targeted for lysosomal degradation 
and 25% is recycled to the plasma membrane. Most of the internalized 
GHR is degraded therefore rapid receptor synthesis is required to 
maintain the GH binding capacity of the cells (Roupas & Kterington^ 
1988) 
1.2.3 Regulation of GHR Level 
GHRs are essential to the molecular mechanism of GH action, so 
modulation of these receptors could significantly alter the biological 
responses of the target tissues to GH. GH itself plays a significant role in 
GHR regulation. In rat, streptozotocin-induced diabetes, fasting and renal 
insufficiency, markedly reduced GH secretion and a low hepatic receptor 
level is found (Baxter et al., 1980; Finidori et al., 1980). Adipocytes 
isolated from hypophysectomized rat have low GH binding. After 
treatment with bovine GH, receptor level was increased twofold 
(Grichting & Goodman/ 1986). GH binding in liver membranes of 
hypophysectomized and normal rat is increased after infusion of GH by 
minipump for seven days (Baxter & Zaltsman^ 1984). It has recently been 
demonstrated that elevated levels of ovine GH expressed as a transgene in 
mice are capable of inducing hepatic GHR (Orian et al, 1991). 
8 
In some studies, GHR appears to be down regulated by GH. For example 
when human lymphocytes (IM-9 line) were exposed to human GH (hGH) 
for two hours, the binding of 125 l-hGH was reduced for about 50% 
(Lesniak and Roth, 1976). In addition, hepatic GH binding in 
hypophysectomized rat was reduced for 53% after single injection of GH 
(Maiter et al., 1988). Down regulation of GHR was also observed in the 
liver of posthatch and young chicken due to the high circulating GH 
concentration during this period (Vanderpooten et al., 1990). 
Insulin also regulates the concentration of GHRs. The reduced number of 
hepatic GHRs in rats with streptozotocin- induced diabetes is partially 
restored by insulin treatment (Baxter et al., 1980). Furthermore, GHR 
have been found to be reduced in number in livers of rats with chronic 
renal insufficiency, a condition marked by normal circulating GH levels 
but low insulin levels (Finidori et al,, 1980). The receptor loss correlated 
with decreased serum insulin was reversed by insulin therapy. 
Estrogens also play an important role in regulation of GHR. A twofold 
increase in GH binding was demonstrated in the liver of female rats after 
puberty, but no such increase was observed in male rats (Maes et al., 
1983). Pregnancy results in a 10-fold increase in GH binding to liver 
membrane in rats and a twofold increase in rabbit (Roupas & Herington^ 
1989). 
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1.2.4 Structure of GHR 
The cloning and sequencing of the complementary DNA (cDNA) to the 
liver GHR of different animals has provided important information on the 
structure of the receptor. cDNAs of human and rabbit GHR were first 
cloned by Leung et al (1987). The primary structure of the mature 
transmembrane GHR, as deduced from the nucleotide sequence, 
represents a protein of about 620 amino acids. GHR from different 
animals are slightly different in the number of amino acids. Based on the 
data from the hydropathy plot, GHR can be divided into three regions : 
the N-terminal extracellular hormone binding domain, the transmembrane 
domain and the cytoplasmic domain (Leung et al., 1987) (Figure 1.1). 
O 100 200 300 400 500 600 620 
Transmembrane domain ^ ^ 
signal ^ ^ ^ ^ ^ ^ 
r r • I 
Extracellular domiain Cytoplasmic domain 
—— fVV^  ： S / k v V ^ \ 
Figure 1.1. Schematic rq)resentation of human GHR. The hydropathy plot was produced 
using a window of 10 amino acid residues; positive values indicate increasing hydrophobicity. 
(adapted from Leung et al, 1987). 
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The extracellular hormone binding domain contains seven cysteine 
residues and five potential glycosylation sites which are conserved among 
the cloned GHRs (Figure 1.2). The mammalian and avian GHRs so far 
cloned share approximately 70% overall amino acid similarity ( Kelly et 
al., 1993). 
1 
Asn(28) L Cys (38) 
— C y s (48) 
— C y s (83) 
Asn(97) - — Cys (94) � “ - C y s (108) Asn(i38) — — Cys (122) Extraccllular domain 
Asn ( 1 4 3 ) — 
Asn ( 1 8 2 ) — 
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Figure 1.2. Schematic representation of GHR. Transmembrane domain is shown as a black 
box. Extracellular cysteines (Cys) are shown at the right, and asparagines (Asn), which are 
potQitial sites of glycosylation, are at the left (adapted from Kelly et al., 1993) 
The purified GHR from rabbit liver was characterized by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. The molecular weight of the 
purified receptor is about 130,000 (Leung et al,, 1987). The molecular 
weight of the deglycosylated receptor is about 95,000 which is much 
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greater than the molecular weight of 70,000 calculated from the deduced 
amino acid sequence. Up to now, no detailed explanation for the 
difference in apparent molecular weight of the deglycosylated receptor 
and the theoretical molecular weight has been found. 
In some studies, it was found that heterogeneous population of GHRs 
may exist. In mouse liver, three specific mouse GH binding proteins or 
receptors with molecular weights about 125,000 , 62,000 and 56,000 
were detected by radiolabeled mouse GH (Smith &Talamantes, 1987). 
Northern analyses of mRNA isolated from rabbit liver tissue, using rabbit 
GHR cDNA fragment as probe, demonstrated the existence of three GHR 
transcripts with molecular weights about 4.2, 6.6 and 12.5 kb(Glmmi et 
al., 1990). These transcripts may encode for different GHR species. 
As mentioned above, apart from GHR that can cross-link with GH, a 
soluble from of GHBP was identified in several species of animals. There 
is amino acid identity between the amino-terminal sequence of the GHR 
and the GHBP (Leung et al., 1987). Therefore it is believed that they 
come from the same origin. Two independent mechanisms have been 
proposed for the production of the GHBP. First, it is generated by the 
specific proteolysis of the membrane form receptor. In human and rabbit 
the serum GHBP probably results from proteolytic cleavage of the 
receptor because only a single mRNA transcript of 4.5 kb is identified by 
Northern analysis and also two potential trypsin-like cleavage sites are 
present within the extracellular domain which are very close to the 
transmembrane domain (Leung et al., 1987). The second mechanism 
proposed is that GHBP comes from the translation of an alternatively 
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spliced mRNA produced from the same gene. In the livers of mouse and 
rat, two mRNAs of approximately 4.5 kb and 1.5 kb are detected by 
Northern analysis which encode the membrane receptor and GHBP 
respectively( Smith & Talamantes, 1897; Baumbach et al； 1989). 
Although the exact fimction(s) of GHBP is still unknown, there is a 
possibility that GHBP may play an important role in the enhancement of 
GH activity. In vivo studies have shown that GH preincubated with 
GHBP prior to injection into GH-deficient rats resulted in a greater 
potency than GH alone in stimulating weight gain, bone growth and 
serum IGF-I levels. The enhancement of GH activity may be due to the 
increased in half life of GH after binding to GHBP (Herington, 1994). 
1.2-5 Possible Signal Transduction Pathways of GHR 
Very little is known about the early events that occur after the binding of 
GH to its receptor on the plasma membrane. In 1981, Vesely has 
demonstrated that rat and human GH are able to enhance the activity of 
the guanylate cyclase-cyclic GMP system. 
The identification of the primary amino acid sequence of GHR does not 
provide any information about the signal transduction mechamsm. For 
example, sequences of the GHRs do not reveal homology to any known 
tyrosine kinase. 
However Carter-Su et al. (1989) have demonstrated that kinase activity is 
present in the purified GHR. The kinase is specific for tyrosine by 
analyzing the phosphoamine acid content of the GHR following 
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phosphorylation in solution using [Y-32p] ATP. They also suggested that 
the GHR itself is a tyrosine kinase that undergoes autophosphorylation or 
GHR is a substrate for a tightly associated tyrosine kinase. 
Recent findings suggested that GHR forms a complex with a tyrosine 
kinase capable of phosphorylating the receptor (Wang et al, 1992). This 
means that the receptor protein itself is not a tyrosine kinase, it requires 
an associated tyrosine kinase. The cloned mouse GHR cDNA was 
transfected to a GH non-responsive cell line, COS 7 monkey kidney cells. 
GH binding in the transfected COS 7 cells was 2 to 20 times higher than 
that in the non-transfected 3T3-F442A fibroblasts (a GH responsive cell 
line). The GHR was purified from both cell cultures and phosphorylated 
in vitro. COS 7 cells transfected with GHR cDNA had a higher level of 
GH binding than the non-transfected 3T3-F442A fibroblasts, however the 
amount of phosphorylated GHR is much less than the 3T3-F442A 
fibroblasts when both of them were treated with GH. This suggested that 
the level of GHR present in a cell is not directly proportional to the 
amount of phosphorylated GHR after GH stimulation. Phosphorylation of 
GHR seems to require a tyrosine kinase which is originally present inside 
theceU (Wmget al, 1992). 
Argetsinger et al (1993) have recently identified a 130 kd tyrosine kinase 
called JAK2 in GH responsive tissues which associates with GHR 
following binding of GH and initiates phosphorylation of GHR and also 
JAK2 itself. They suggested that the binding of GH by GHR results in the 
formation of a ligand-bound GHR dimer due to one GH molecule capable 
to bind two GHR ( Cunningham et al., 1991); the ligand-bound GHR 
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dimer then binds to a JAK2 molecule. The formation of GH-GHR-JAK2 
complex leads to the stimulation of JAK2 tyrosine kinase activity and 
then tyrosyl phosphorylation of JAK2 and GHR. The identification of 
JAK2 tyrosine kinase provides a direct evidence to prove that the 
receptor itself is not a tyrosine kinase and the phosphorylation of GHR 
requires an associated tyrosine kinase. 
Protein kinase C activation could be involved in the mechanism of action 
of GH, as suggested by several reports. GH is able to stimulate 
phospholipase C activity in vitro with the production of inositol 
triphosphate and diacylglycerol in basolateral membranes of canine 
kidney (Rogers & Hammerman^ 1989). GH has also been shown to 
stimulate the production of diacylglycerol by means of 
phosphatidylcholine breakdown in mouse preadipocytes (Catalioto et al., 
1990). In isolated hepatocytes GH is able to stimulate the production of 
diacylglycerol rapidly. Diacylglycerol is known to activate protein kinase 
C. These findings therefore suggest that protein kinase C could mediate at 
least some of the actions of GH in these models. 
1.2.6 GHR related Dwarfism 
Dwarfism can be caused by various factors such as defect of pituitary 
gland, lack of responsiveness in target tissue, defect in IGF and / or its 
receptor, etc. In 1966 Laron identified a specific type of dwarfism in 
human called "Laron type dwarfism��(LTD) characterized by severe 
growth failure and low circulating levels of IGF-I in spite of normal or 
elevated level of GH, which appeared to be biologically active. Amselem 
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et al. (1989 & 1991) identified non-sense mutations within GHR gene of 
LTD patients, lying at positions corresponding to the amino terminal and 
causing a truncation of the GHR molecule, thereby leading to the absence 
of GHR binding activity. Furthermore Godowski et al. (1989) identified 
single point mutation in GHR gene of LTD patients. The mutation 
changing phenylalanine to serine at position 96 of the extracellular 
hormone binding domain of the mature GHR. The mutated GHR fail to 
follow the intracellular transport pathway, therefore accumulate inside the 
cell and are not transported to the plasma membrane. 
In addition to human, another type of dwarfism related to GHR called sex 
linked dwarfism (SLD) has been identified in male chicken. These 
chickens, like LTD patient, have elevated level of GH and low level of 
plasma IGF-L A defect in the chicken GHR gene that results in the 
formation of a very small 0.7 kb mRNA transcript was observed by 
Northern analysis, rather than the 4.3 kb in normal chicken. The small 
transcript would contain an insufficient coding region for a functional 
GHR protein (Bumside et al, 1992). 
1.2.7 Significance of Cloning of GHR cDNA 
Cloning of GHR cDNAs are essential because this can provide 
information about the receptor protein structure such as its anchorage in 
the cell membrane. It can allow scientists to find out whether more than 
one type of GHR exists. Together with transfection technique, it can 
allow scientists to establish in vitro system to study signal transduction 
mechanisms of GH. The presence of GHR cDNAs allow detection of 
16 
GHR mRNA in different tissues by Northern analysis. For some tissues, 
GH binding site are not always detectable but mRNA transcripts of GHR 
can be identified. Following identification, the action of GH in these 
tissues can be investigated. 
In addition, the cloning of GHR cDNAs has clinical significance. Cloning 
of GHR cDNA in human allow scientists to identify the mutations in 
GHR gene in LTD patients. High level expression of extracellular domain 
of GHR may have therapeutic potential because the secreted GHR 
extracellular domain can bind the ciculating GH. Therefore it may serve 
as a regulator in the patient with excessive GH secretion such as in 
acromegaly (Ota et al., 1991). 
1.3 Objectives of The Present Study 
The present study is divided into three parts. The first part is the cloning 
of chicken GHR cDNA using polymerase chain reaction (PCR) and the 
cloned cDNA is used as a probe in ontogeny studies on chicken hepatic 
and brain GHR mRNA. The second part of this study is the molecular 
cloning of pigeon GHR cDNA. Several mammalian GHR cDNA were 
cloned and these cDNA share about 90% nucleic acid sequence 
homology. However the homology of mammalian GHR cDNA to the 
chicken one (the only avian so far cloned) is only about 6,0%. There is a 
possibility that evolutionary variation has occurred in GHR. Therefore 
cloning of pigeon GHR cDNA can provide us more information about the 
structure of avian GHR. And the pigeon GHR cDNA can serve as a tool 
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for study the signal transduction mechanism of avian GH. The last part is 
the preliminary studies on the cloning offish (Dace) GHR cDNA. Hepatic 
GHR was characterized by binding studies in several species of fish (Ng 
et al., 1991; Hirano, 1991; Ng et al., 1992; Mori et al., 1992). It is 
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Chapter 2 General Materials and Methods 
2.1 Ethanol Precipitation of DNA and RNA 
Two volumes of ice-cold absolute ethanol was added to a DNA solution 
(2.5 volumes for RNA). 3M sodium acetate (pH 5.2) was added to a final 
concentration of 0.3M. The ethanolic solution was kept at -TO^C for 30 
minutes. The precipitated DNA (RNA) was collected by centrifugation at 
12,000g for 15 minutes at in a microcentrifuge (Eppendorf 5414). 
After centrifugation the DNA (RNA) pellet was washed with 70% ethanol 
and recovered by centrifugation again. The DNA (RNA) pellet was air-
dried, and dissolved in appropriate amount of water (DEPC-treated water 
for RNA). 
2.2 Spectrophotometric Determination of DNA and RNA 
The amount of nucleic acid was determined by spectrophotometry 
(Beckman DU® 7500) and readings were taken at wavelengths of 260mn 
and 280mn. An OD26O of 1 corresponds to approximately 50 jig/ml for 
double-stranded DNA, 40 |ig/ml for single-stranded DNA and RNA, and 
20 lig/ml for single-stranded oligonucleotides. The purity of nucleic acids 
was determined by the ratio between the absorbance at 260mn and 280mn. 
Pure preparations of nucleic acids have OD26O/OD28O value of 1.8 or 
above. 
2.3 Minipreparation of Plasmid DNA 
The method was adopted from Sambrook et al (1989) with minor 
modifications. A single bacterial colony was inoculated into 1.5 ml Luria 
Bertani (LB) medium containing the appropriate antibiotic in a capped 
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sterile tube. The culture was incubated overnight at 37^0 with vigorous 
shaking. The bacterial cells were collected by centrifugation at 12,000g for 
one minute at room temperature in a microcentrifuge. The bacterial pellet 
was resuspened in 300 |il Buffer PI. Then 300 |il Buffer P2 was added and 
the mixture was kept on ice for 5 minutes. After 300 jal P3 was added, the 
mixture was centrifuged at 12,000g for 15 minutes at room temperature. 
The compositions of Buffers PI, P2 and P3 are described in section 2.27.2. 
The supernatant was transferred to a fresh 1.5 ml eppendorf tube. The 
plasmid DNA was recovered by ethanol precipitation (section 2.1) and was 
dissolved in 30 |uil water. 
2.4 Preparation of Plasmid DNA using Magic™ Minipreps 
DNA Purification Kit from Promega 
The following procedure is based on the method recommended by the 
supplier. A single bacterial colony was inoculated into 3 ml LB medium 
containing the appropriate antibiotic in a capped sterile tube. The culture 
was incubated overnight at 3 7 � � w i t h vigorous shaking. The bacterial cells 
were collected by centrifiguation at 12,000g for one minute in a 
microcentrifuge. The bacterial pellet was resuspended in 200 [d 
Resuspension Buffer (50 mM Tris-HCl (pH7.5), 10 mM EDTA, 100 jig/rnl 
RNase A). 200 |il of Lysis Buffer (0.2 M NaOH, 1% SDS) was added to 
lyse the bacterial cells. Then 200 jiil Neutralization Buffer (2.55 M KOAc 
(pH 4.8) )was added. The mixture was centrifuged at 12,000g for 5 
minutes in a microcentrifuge. The supernatant was transferred to a fresh 
1.5 ml eppendorf tube and 1 ml Magic Minipreps DNA Purification Resin 
was added. A Magic Minipreps Column was attached to a 3 ml syringe 
barrel. Then the supernatant / Resin mixture was added into the barrel and 
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was pushed gently into the column. The column was washed with 2 ml 
Column Wash Solution (100 mM NaCL, 10 mM Tris-HCl (pH 7.5), 2.5 
mM EDTA, 50% EtOH). The column was centrifuged for 30 seconds in a 
microcentrifuge to remove the last trace of solution. 50 [xl 65^C pre-heated 
water was added to the column. The column was then attached to a fresh 
1.5 ml eppendorf tube. Solution containing the plasmid DNA was collected 
by centrifugation at 12,000g for 30 seconds in a microcentrifuge. 
2.5 Preparation of Plasmid DNA using QIAGEN-tip 100 
The method was adopted from the QIAGEN plasmid handbook (1992). A 
single bacterial colony was inoculated into 150 ml LB medium containing 
appropriate antibiotic. The culture was incubated overnight at 37^C with 
vigorous shaking. The bacterial cells were collected by centrifugation at 
6000g for 15 minutes at The bacterial pellet was resuspended in 4 ml 
Buffer PI containing 100 |ig/inl RNase. 4 ml of Buffer P2 was added and 
the mixture was kept on ice for 5 minutes. After 4 ml Buffer P3 was added, 
the mixture was allowed to stand on ice for 15 minutes or more. The 
mixture was centrifuged at 30,000g for 30 minutes at The supernatant 
was transferred to a fresh tube. A QIAGEN- Tip 100 (QIAGEN Inc.) was 
equilibrated with 4 ml QBT, and the tip allowed to empty by gravity flow. 
The supernatant from the previous step was applied onto the tip. After the 
tip was emptied, it was washed with 10 ml QC twice. The plasmid DNA 
adsorbed onto the tip was eluted by 5 ml buffer QF. The eluted plasmid 
DNA was recovered by adding 0.7 volume of isopropanol. The mixture 
was kept at room temperature for 30 minutes and then centrifuged at 
15,000g for 15 minutes at The pellet was washed with 70% ethanol 
and recovered by centrifugation again. The plasmid DNA pellet was air 
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dried and dissolved in an appropriate amount of water. Compositions for 
OBT, QC and QF are described in section 2.27.2. 
2.6 Preparation and Transformation of Escherichia coli 
Competent Cell 
Appropriate strain of Escherichia coli (E.coli) was streaked directly from 
frozen stock onto the surface of a LB agar plate and incubated overnight at 
37OC. A single colony from the plate was transferred to 10 ml Psi medium 
and shaked vigorously at 37^C for 2 hours. Then the 10 ml culture was 
inoculated into 100 ml Psi medium. The cells were grown at 37^C until 
ODgoO reached 0.45. The culture was chilled on ice for 15 minutes. The 
cells were harvested by centrifugation at lOOOg for 15 minutes at 
(Beckman superspeed centrifuge J2-21, rotor JA 14) . The cell pellet was 
resuspensed in 37 ml RF 1 and kept on ice for 15 minutes and was 
transferred to a fresh centrifuge tube. The cells were then collected by 
centrifugation at lOOOg for 15 minutes at (Beckman superspeed 
centrifuge J2-21, rotor JA 20). The cell pellet was resuspended by 8 ml RF 
2 and kept on ice for 15 minutes. The competent cell suspension was 
dispensed into aliquots of 200 |il each and flash frrozen in liquid nitrogen. 
The competent cells were stored at -lO^C before use. 
Appropriate amount of plasmid DNA (usually 10 ng) or ligation mixture 
was added to a tube containing 200 jil of just thawed competent cells and 
mixed well. The tube was kept on ice for 30 minutes and then heat-
shocked at 420C for exactly 2 minutes. The tube was rapidly transferred to 
ice bath to chill the cell for 2 minutes. Then 0.4 ml 37^C pre-warmed LB 
medium was added to the tube. The tube was incubated at 37^C for 45 
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minutes. After incubation, 50 |LI1 of the culture, 50 jil 5-bromo-4-chloro-3-
indolyl-P-D-galactoside (20 mg/ml) and 20 |LI1 0.1 M isopropylthio-p-D-
galatoside (IPTG) were mixed and spread onto a LB plate containing 
appropriate antibiotic. After the liquid had been absorbed, the plate was 
inverted and incubated at 37^0 overnight. Compositions for LB, Psi, RF 1 
and RF2 are described in sections 2.27.1 and 2.27.5. 
2.7 Rapid Screening for the Presence of Desired Plasmid 
The presence of desired plasmid in the transforaiants were determined by 
rapid alkaline lysis method (Barnes, 1977). The transformed E. coli cells 
were allowed to grow to 2 to 3mm in size on LB plate containing 
appropriate antibiotic. The colony was then transferred by a sterile 
toothpick to a 1.5 ml eppendoif tube containing 15|il rapid alkaline lysis 
buffer (50 mM sodium hydroxide, 0.5% SDS, 5 mM EDTA and 0.025% 
bromocresol green). The eppendoif tube was capped and incubated at 
680C for an hour. The mixture was then loaded to a 1% Tris-borate (TBE) 
gel without the addition of ethidium bromide and the two ends of the gel 
just touching the running buffer. When the dye had migrated into the gel, 
more running buffer might be added to submerge the gel. After 
electrophoresis, the gel was stained by soaking for 45 minutes in a solution 
of ethidium bromide (0.5 jig/ml). 
2.8 Agarose Gel Electrophoresis 
DNA was separated by 1 to 2% TBE / Tris-acetate (TAE) agarose gel, 
which was prepared by dissolving 1 to 2% agarose (w/v) in IX TBE / 
TAE，containing 0.5 |ag/ml ethidium bromide. The DNA sample was mixed 
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with appropriate amount of 6X agarose gel loading buffer to give a final 
concentration IX. Then the sample was loaded into the slots of the gel 
which was placed into the electrophoresis tank and covered by IX TBE / 
TAE electrophoresis buffer. A voltage of 8 V/cm was applied. After the 
bromophenol blue was migrated for an appropriate distance through the 
gel, the gel was examined under ultraviolet light. Polariod instant 
photograph was taken by a Polaroid MP-4 instant camera, compositions for 
TBE and TAE are described in section 2.27.3 
2.9 Formaldehyde / Agarose Gel Electrophoresis. 
Total RNA or mRNA was fractionated by 1% formaldehyde /agarose gel 
which was prepared by mixing 3.5 parts of agarose in water, 1.1 parts of 
5X formaldehyde gel running buffer and 1 part of 12.3M formaldehyde 
solution. The gel was pre-run for 5 minutes at 50V before loading samples. 
4.5 1^1 of RNA solution (up to 30 jig) was mixed with 2 jil 5X 
formaldehyde gel running buffer, 3.5 jil formaldehyde and 10 jul 
formamide. The mixture was incubated at 6 5 � � f o r 15 minutes to denature 
the RNA and then chilled on ice. After chilling, 2 \il formaldehyde gel-
loading buffer was added to the mixture. Then the mixture was loaded into 
a slot of the gel which was placed into the electrophoresis tank and 
covered with IX formaldehyde gel-running buffer. A voltage of 5 V/cm 
was applied. After the bromophenol blue had migrated approximately 7 
cm, the gel was stained with ethidium bromide (0.5 \xg/m[ in DEPC-treated 
water) for 45 minutes. After staining, the gel was examined under 
ultraviolet illumination. Polariod instant photograph was taken by a 
Polaroid MP-4 instant camera. Compositions for formaldehyde gel-running 
and formaldehyde gel-loading buffer are described in section 2.27.4 
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2.10 Restriction Digestion of DNA 
Restriction digestion of DNA was carried out in a volume of 20 to 100 |il 
in the appropriate buffer as suggested by the supplier. The reaction was 
incubated at the optimal temperature of the restriction enzyme for an hour 
or longer. After digestion, the reaction mixture was analysed by agarose 
gel electrophoresis. 
2.11 Linearization and Dephosphorylation of Plasmid Vector 
5 |ig of plasmid vector was digested with 50 units of suitable restriction 
eiizyme(s) in a 50 |il reaction mixture (section 2.10). After complete 
digestion 5.5 |il of lOX calf intestine phosphatase (CEP) buffer and 1 unit 
of alkaline phosphatase was added and incubated at 37^C. After 30 
minutes 1 more unit of alkaline phosphatase was added and incubated 30 
minutes more. After incubation the mixture was extracted by phenol / 
chloroform extraction (section 2.13). The aqueous phase was collected and 
the plasmid was precipitated by ethanol precipitation. The linearized and 
dephosphorylated plasmid was finally dissolved in 20 pi water. The 
composition of the lOX CIP buffer was described in section 2.27.8. 
2.12 Purification of DNA from Agarose Gel using 
GENECLEAN H® Kit 
The following procedure is based on the method recommended by the 
supplier (Bio 101). DNA sample was separated by TAE gel. The TAE gel 
stained with ethidium bromide was observed under ultraviolet illumination. 
The band containing the desired DNA was cut out from the gel using a 
razor blade. The weight of the gel slice was determined and 3 volumes of 
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6M sodium iodide solution was added. After melting the gel at 5 5 � � f o r 5 
minutes, 10 [il Glassmilk® was added. The mixture was kept on ice for 15 
minutes. The mixture was centrifiiged in a microcentrifuge at 12,000g for 1 
minute. The pellet was washed with 0.7 ml New Wash solution. The 
suspension was pelleted by centrifugation again. The washing procedure 
was repeated for two more times. The washed pellet was air dried and then 
resuspended with 20 |il water. After incubation at 55^C for 3 minutes the 
mixture was centrifuged in a microcentrifuge at 12,000g for 1 minutes and 
the supernatant containing the DNA was collected. 
2.13 Purification of DNA by Phenol / Chloroform Extraction 
The sample DNA solution was mixed with an equal volume of phenol / 
chloroform mixture (phenol : chlorofrom : isoamyl alcohol = 25 : 24 : 1 
volume by volume). After extraction by vigorous vortexing, the mixture 
was centrifuged at 12,000g for 2 minutes in a microcentrifuge. The 
aqueous phase containing the DNA was collected and then precipitated by 
ethanol precipitation. The DNA was dissolved in an appropriate amount of 
water and was analyzed by agarose gel electrophoresis. 
2.14 DNA Radiolabelling 
DNA was labeled with [cc32p]dCTP by random priming method using the 
Oligolabelling Kit from Pharmacia. The following procedure is based on 
the method recommended by the supplier. 20 to 50 ng of DNA was 
dissolved in 34 |al water. The DNA solution was denatured at lOO^C for 3 
minutes, and was then chilled on ice for 2 minutes. 10 jil of Reagent Mix, 
5 of [(x32p]dCTP (10 mCi/ml, Amersham) and 10 units of Klenow 
fragment were added to the denatured DNA solution. The mixture was 
26 
incubated at 37^C for an hour. After incubation, the labelled DNA was 
purified by spun-column chromatography (section 2.15). 
2.15 Spun -Column Chromatography 
The [a32p]dCTP labeled DNA was purified from the unincorporated 
nucleotides by spun-column chromatography. The method was adopted 
from Sambrook et al. (1989) with minor modifications. The bottom of a 1 
ml disposable syringe was pluged by a small amount of sterile glass wool. 
Then the syringe was filled with water equilibrated Sephadex G50 resin. 
The filled syringe was inserted into a 15 ml disposable plastic tube and was 
centrifuged at 1600g for 4 minutes in a swinging bucket rotor centrifuge. 
More resin was added and centrifuged again until the volume of the packed 
column is approximately 0.9 ml. After the column was packed, it was 
inserted into a fresh 15 ml plastic tube containing a decapped 1.5 ml 
eppendorf tube. Labelled DNA solution was added into the colunrn. The 
plastic tube together with the column was spun at 1600g for 4 minutes. The 
column was removed and the eppendorf tube containing the eluted DNA 
was taken out from the plastic tube by a forcep. After the tube was capped, 
the eluted DNA was stored at -20^C before use. 
2.16 Capillary Transfer of DNA/RNA to a Nylon Membrane 
The method was adopted from Sambrook et al (1989) with minor 
modifications. DNA was denatured before transfer. 
2.16.1 DNA Denaturation 
After electrophoresis, the unused areas of the IX TBE agarose gel was 
trimmed away with a razor blade. The trimmed gel was soaked for 45 
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minutes in several volumes of denaturing solution (1.5M sodium chloride, 
0.5M sodium hydroxide) at room temperature to denature the DNA. After 
denaturation, the gel was washed briefly with distilled water and then 
neutralized by soaking for 30 minutes in several volumes of neutralizing 
solution ( IM Tris-HCl, pH 7.4, 1.5M sodium chloride). 
2.16.2 Capillary Transfer 
The gel was washed with lOX SSC at room temperature for 30 minutes. 
After washing, the gel was transferred to a Whatman 3MM filter paper 
which was placed on the top of a sponge in a transfer tank. Then the gel 
was covered with a lOX SSC wetted Hybon-N nylon membrane (same size 
as the gel), followed by two 1 OX SSC wetted Whatman 3MM filter paper 
and then two pieces of dry filter paper. 5cm high paper towel was placed 
on the top of the setup. A glass plate was put on the top of the paper towel 
and it was weighed down by a 500g weight. Then the transfer tank was 
filled with lOX SSC. After overnight transfer, the membrane was washed 
with 2X SSC at room temperature for 30 minutes and the gel was stained 
with ethidium bromide (0.5 iiig/ml in water) to see whether the transfer was 
sucessful or not. After washing, the membrane was illuminated under 
ultraviolet light in a DNA transfer lamp (Fotodyne) for two minutes. The 
membrane was stored in a dessicator before use. Composition for SSC is 
described in section 2.27.6. 
2.17 Hybridization of DNA/RNA 
The following procedure was adopted from Sambrook et al (1989) with 
minor modifications. The DNA / RNA immobilized Hybon-N membrane 
was prehybridized in Prehybridization solution containing 100 i^g/ml 
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denatured, fragmented calf thymus DNA at 55^0 for 3 hours in a 
hybridization tank. After prehybridization, the Prehybridization solution 
was discarded and Hybridization solution containing 100 |Lig/ml denatured, 
fragmented calf thymus DNA was added immediately. The [a32P]dCTP 
labelled DNA probe was denatured by heating for 5 minutes at 95^C and 
then added to the hybridization tank. The membrane was hybridized at 
55^C for 16 hours in the hybridization tank with gentle shaking. After 
hybridization, the membrane was washed with 4X SSC containing 0.1% 
SDS at room temperature for an hour and followed by washing 2 times 
with 2X SSC containing 0.1% SDS at 55^0 for an hour. Then the 
membrane was wrapped with Saran wrap carefully. Autoradiography was 
done to detect the signal. 
2.18 Autoradiography 
Kodak X-OMAT AR diagnostic film or Fuji RX medical X ray film was 
used for detecting the signal of Northern analysis. Southern analysis and 
DNA sequencing. Films were exposed in a Kodak X-Omatic cassette at -
70OC for one day to one week. After exposure, the films were developed 
with Kodak X-ray developer for 5 minutes, fixed with Kodak X-ray fixer 
for 5 minutes and rinsed with running water for 5 minutes. 
2.19 Preparation of Ribonuclease Free Reagents and 
Apparatus 
General laboratory glassware was treated by baking at ISO^C for 8 hours 
or more. Other items which were not susceptible to baking were treated 
with diethyl pyrocarbonate (DEPC, 0.1% (v/v) in water). All solutions 
were treated with 0.1% DEPC for at least 12 hours and then autoclaved at 
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1210c for 15 minutes on liquid cycle. Sterile, disposable plasticware was 
used for the preparation and storage of RNA without pretreatment. 
2.20 Total RNA Isolation 
Total RNA of a tissue was isolated by acid guanidinium thiocyanate-
phenol-chloroform extraction method (Chomczynski & Sacchi, 1987). 
About 50 mg of tissue was homogenized at room temperature with 0.5 ml 
Extraction Buffer in a hand-driven homogenizer. The homogenate was 
transferred to a 1.5 ml eppendorf tube and 50 |il of 2M sodium acetate (pH 
4.0), 0.5 ml phenol ( Tris-HCl saturated), and 100 [d of chloroform-
isoamyl alcohol mixture (49 : 1, by volume) were added to the 
homogenate. The mixture was shaken vigorously for 10 seconds and kept 
on ice for 15 minutes. The mixture was centrifuged at 12,000g for 20 
minutes at in a microcentrifuge. The RNA containing aqueous phase 
was collected and transferred to a fresh eppendorf tube and the RNA was 
precipitated with one volume isopropanol at -70^C for an hour. The 
precipitated total RNA was collected by centrifiigation at 12,000g for 20 
minutes at The RNA pellet was then dissolved in 150 |il Extraction 
Buffer. The RNA was precipitated by one volume of isopropanol again at -
70OC for an hour and then recovered by centrifugation at 12,000g for 20 
minutes at 4^0. The RNA pellet was washed with 70% ethanol and 
recovered by centrifugation again. The RNA was air dried for 15 minutes 
and then dissolved in 50 i^l 0.5% SDS and stored at -lO^C before use. The 
yield and purity of RNA was determined by spectrophotometry (section 
2.2). Composition for Extraction buffer is decribed insection 2.27.7. 
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2.21 mRNA Isolation 
mRNA of a tissue was isolated by the QuickPrep®Micro mRNA 
Purification Kit from Pharmacia. The following procedure is based on the 
method recommended by the supplier. About 0.1 g tissue was 
homogenized at room temperature with 0.4 ml Extraction Buffer (a 
buffered aqueous solution containing guanidinium thiocyanate and N-
lauroyl sacosine) in a manual homogenizer. Then 0.8 ml of Elution Buffer 
(10 mM Tris-HCl (pH 7.5), 1 mM EDTA) was added to the extract and 
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mixed thoroughly. The homogenate was transferred to a 1.5 ml eppendorf 
tube and centrifugated at 12,000g for 1 minute in a microcentrifuge. The 
clear homogenate was transferred to an eppendorf tube containing 
01igo(dT)-cellulose. The homogenate and 01igo(dT)-celMose was mixed 
gently for 3 minutes. After mixing, the cellulose was collected by 
centrifugation at 12,000g for 10 seconds. The supernatant was discarded 
and the cellulose was washed with 1 ml High-Salt Buffer (10 mM Tris-HCl 
(pH 7.5), 1 mM EDTA, 0.5 M NaCl). The cellulose was pelleted by 
centrifugation again. The High-Salt Buffer washing procedure was 
repeated 4 more times. Then the cellulose was washed 3 times with Low-
Salt Buffer (10 mM Tris-HCl (pH 7.5)，1 mM EDTA, 0.1 M NaCl). After 
washing, the cellulose pellet was resuspended in 0.3 ml Low-Salt Buffer 
and was transferred to a Microspin Column placed in a 1.5 ml eppendorf 
tube. The column was spun at 12,000g for 5 seconds in a microcentrifuge. 
The effluent in the eppendorf tube was discarded. Then 0.5 ml Low-Salt 
Buffer was added into the column, followed by centrifugation again. This 
step was repeated for 2 more times. After washing, the column was 
inserted into a fresh eppendorf tube and 0.4 ml pre-heated (650C) Elution 
Buffer was added to the column. Solution containing the mRNA was 
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collected by centrifugation at 12,000g for 5 seconds in a microcentrifuge. 
The yield and purity of the mRNA was determined by Spectrophotometry 
(section 2.2). 
2.22 First Strand cDNA Synthesis 
Total RNA or mRNA was reverse-transcribed to first strand cDNA by the 
First-Strand cDNA Synthesis Kit from Pharmacia. The following procedure 
is based on the method recommended by the supplier. 1 to 5 jig of total 
RNA or mRNA was dissolved in 20 |il of DEPC-treated water. The RNA 
solution was denatured at 65^C for 10 minutes and then chilled on ice 
immediately. 11 |LI1 of Bulk First-Strand cDNA Reaction Mix, 1 jiil of 200 
mM Dithiothreitol (DTT) solution and 1 |il of chosen primer (5 jig/pl) were 
added to the RNA solution. The mixture was incubated at 37^C for an 
hour. After incubation, the first strand cDNA was stored at -20^C before 
use. 
2.23 Polymerase Chain Reaction (PCR) 
The following method was based on Sambrook et al. (1989) with 
modification. 5 of lOX Vent ™ / Taq Buffer，8 i^l of dNTP mix (1.25 
mM for each nucleotide), 5 |il of forward primer (20 [xM) and 5 |il of 
backward primer (20 i^M) were added into a 500 …eppendorf tube. 
Appropriate amount of template was added to the reaction mixture. Water 
was added to make a final volume of 50 The mixture was incubated at 
940c for 5 minutes to denature the template DNA. After denaturation 2.5 
units of Vent ™ / Taq DNA polymerase was added. The tube was 
vortexed briefly and centrifuged to spin down the liquid. Then 50 fil of 
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light mineral oil was overlaid onto the reaction mixture to prevent 
evaporation of the solution during PCR. 
Amplification was carried out under the following conditions in a 
thermocycler (TEMP. TRONIC, Thermolyne): 
Cycle Denaturation Annealing Polymerization 
1st to 32th 20 seconds 20 seconds 30 seconds 
cycle at 94^C at 55^C at 7 2 � � 
33th cycle 20 seconds 20 seconds 10 minutes 
at 940c at 550c at 
2.24 3’ End Modification of PCR Amplified DNA 
The 3 丨 ragged ends of PCR amplified DNA were modified by the method 
described by Starr & Quaranta (1992). 40 of PCR sample was loaded to 
a TAE gel. The band containing the desired DNA was recovered from the 
gel by the GENECLEAN procedure (section 2.12). 
10 jil of lOX DNA polymerase I buffer, 16 i^l of dNTP mix (1.25 mM for 
each nucleotide), 1 nl of 0.1 M ATP, 10 units of DNA Polymerase I 
(Promega) and 10 units of T4 polynucleotide kinase (Promega) were added 
to the: purified DNA. Water was added to a final volume of 100 The 
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mixture was incubated at After 1 hour incubation, 1 0.5M EDTA 
was added to stop the reaction. 
The modified DNA was again recovered by the GENECLEAN procedure 
(section 2.11). 
2.25 Ligation of DNA Fragments 
The following procedure described the general condition for ligation of 
foreign DNA to a linearized vector. lOOng of the vector and equimolar 
amount of foreign DNA were mixed together. Then lOX ligation buffer 
was added to the reaction mixture to a final concentration of IX. One unit 
(8 units for blunt-end ligation) of T4 DNA ligase (Promega) was added and 
the mixture was incubated overnight at 16^C (room temperature for blunt-
end ligation). 
2.26 DNA Sequencing 
2.26.1 DNA Sequencing Reaction 
Dideoxy-sequencing of plasmid was carried out by the T7 Sequencing Kit 
from Pharmacia. The following procedure is based on the method 
recommended by the supplier. 1-2 jig plasmid DNA was dissolved in 8 |il 
water and mixed with 2 [A of 2M NaOH. The mixture was kept at room 
temperature for 10 minutes for denaturation of the template plasmid. The 
denatured plasmid was recovered by ethanol precipitation (section 2.1) 
and dissolved in 10 |LI1 water. 2 |il of annealing buffer and 2 of primer 
solution (5 |ig/ml) was added to the template solution. The mixture was 
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incubated at 37^0 for 20 minutes and then at room temperatrue for 10 
minutes. 3 |il of Labelling Mix, 1 |il of [a35s]dATP or [oc35s]dCTP 
(lOmCi/ml, Amersham) or [a32p]dCTP (lOmCi/ml, Amersham), 1.6 i^l of 
Enzyme Dilution Buffer and 0.5 units of T7 DNA Polymerase were added 
to the mixture and then incubated at room temperature for 5 minutes. 
During incubation, 2.5 of A-, T-, C-, G- Mix Short was added to four 
labelled fresh 1.5 ml eppendorf tubes and were pre-warmed at 37^C. After 
incubation, 4.5 |il of the reaction mixture was added to each of the four 
pre-warmed Short Mix. The four tubes was incubated at 37^C for 5 
minutes. Then 5 of Stop Solution was added to each tube. The sample 
was then kept at -20^C before use. 
2.26.2 DNA Sequencing Electrophoresis 
A Sequi-Gen® Nucleic Acid Sequencing Cell (Bio-Rad) was used. 
Preparation of 6% polyacrylamide gel solution 
29.4 g of urea , 10.5 ml of 40% acrylamide stock solution (38% (w/v) 
acrylamide, 2% (w/v) N,N'-methylene-bisacrylamide) and 7 ml 1 OX TBE 
buffer were added together. Water was added to a final volume of 70 ml. 
The gel solution was stirred until all the urea had dissolved. 
Casting the gel 
Before casting the gel, the glass surfaces of the casting unit of the 
sequencing cell in contact with the gel were cleaned with distilled water 
and ethanol thoroughly. Then the glass surfaces were wiped with repel-
silane (dimethyldichlorosilane solution 2% (w/v) in 1,1,1-trichloroethane). 
After the glass surfaces were cleaned, a pair of 0.4mm thick spacers was 
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placed between the cleaned glass surfaces. The left and right margins of 
the casting unit were sealed by the clamps provided by the supplier. The 
bottom was sealed by the following procedure - 10 ml of 6% acrylamide 
gel solution, 50 |al TEMED (Bio-Rad) and 125 jiil of freshly prepared 10% 
ammonium persulfate were mixed together. The mixture was poured onto a 
sealing strip inside the casting tray, then the casting unit was placed on the 
top of the sealing strip. 
After the bottom of the casting unit was sealed, it was placed in a inclined 
position (about 20 degrees), 360 |il of freshly prepared 10% ammonium 
persulfate and 35 i^l TEMED (Bio-Rad) was added to the remaining 60 ml 
6% acrylamide gel solution. The gel solution was immediately poured into 
the gap between the glass plates of the casting unit. After pouring, the cell 
was placed horizontally and a 0.4mm thick shark-tooth comb was inserted 
into the gap between the glass plates with its flat side. The gel was allowed 
to set for an hour. 
Electrophoresis 
After the gel was set, the comb was removed and then inserted again with 
its toothed side pointing inward. The casting unit was then assembled onto 
the gel tank. The upper and lower buffer reservoirs were filled with IX 
TBE buffer. The gel was pre-run at a constant power of 40W for 30 
minutes. Before loading, the samples were heated in boiling water for 2 
minutes. 3 |il of sample was loaded into the well using a sequencing pipette 
(Drummond). The gel was then run at a constant power of 40W. After 4-6 
hours, electrophoresis was stopped. The casting unit was dissembled and 
the gel was fixed by 10% (v/v) acetic acid for 15 minutes in a fixing tank. 
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Then the gel was blotted onto a sheet of 3MM Whatman filter paper. A 
piece of Saran wrap was used to cover the gel surface. The gel was dried 




2.27 Reagents and Buffers 
2.27.1 Media for Bacterial Culture 
Luria-Bertani (LB) medium 
Tryptone lOg 
Yeast extract 5g 
NaCl lOg 








Make to 1 liter with distilled water, pH7.2, autoclaved at 121^0 for 15 
minutes. 
2.27.2 Reagents for Preparation of Plasmid DNA 
PI 
Tris-base 6.06 g/l 
Na2EDTA 3.36 g/l 
RNase 100 jig/ml of PI buffer 
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P2 
NaOH 8 g/I 
SDS lo/o 
P3 
KAc (pH 4.8) 250.06 g/1 
QBT 
NaCl 43.83 g/1 
MOPS 10.47 g/1 
Ethanol 15% 
Triton X-100 0.15% 
pH7.0 
QC 
NaCl 73.05 g/1 




NaCl 87.66 g/1 
MOPS 10.47 g/1 
Ethanol 15% 
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2.27.3 Buffers for Agarose Gel Electrophoresis 
TAE (Tris-acetate), IX 
Tris-base 4.84 g/1 
Na^EDTA 0.34 g/1 
Acetic acid 20 mM 
TBE (Tris-borate), IX 
Tris-base 10.9 g/1 
Na2EDTA 0.68 g/1 
Boric acid 5.56 g/1 
6X Agarose gel loading buffer 
Sucrose 40% (w/v) 
Bromophenol blue 0.25% (w/v) 
2.27.4 Buffers for Formaldehyde Gel Electrophoresis 
5X Formaldehyde gel-running buffer 
MOPS 20.6 g/1 
NaAc 3.28 g/1 
NazEDTA 1.7 g/1 
Formaldehyde gel-loading buffer 
Glycerol 50% 
Na^EDTA 0.34 g/1 
Bromophenol blue 0.25% (w/v) 
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2.27.5 Buffers for Preparation Competent Cells 
RFl 
RnCl 12 gA 
MnCl2.4H20 9.9 g/1 
KAc 3 g/1 
CaCl2.2H20 1.5 g/1 
Glycerol 15% 
Adjust to pH 5.8 with acetic acid, filter sterilized 
RF2 
MOPS 2.09 g/1 
RbCl 1.2 g/1 
CaCl2.2H20 llg/1 
Glycerol 15% 
Adjust to pH 6.8 withNaOH, filter sterilized 
I 
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2.27.6 Buffers for Capillary Transfer and Hybridization 
lOX ssc 
NaCl 87.7 g/1 
sodium citrate 44.1 g/1 
Adjust to pH 7.0 with NaOH, autoclaved at 1 2 1 � � f o r 15 minutes 
SOX Denhardfs reagent 
Ficoll 10 g/1 
Polyvinylpyrrolidone 10 g/1 
Bovine serum albumin lOg/1 
Prehybridization buffer 
6X SSC 






2.27.7 Buffers for Total RNA Extraction 
Extraction Buffer 
Guanidinium thiocyanate 1348 g/1 
Sarcosyl 0.8% 
Sodium citrate 11.2 g/1 
p-mercaptoethanol 7.2 ml per liter of Extraction buffer 
2.27.8 lOX CIP Buffer 
ZnCl2 1 . 3 6 4 g/1 
MgCl2 0.953 g/1 
Tris 2.11 g/1 
I 
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2.28 Size of DNA / RNA Molecular Weight Markers 
Size of DNA molecular weight markers 
X Hind m X BstE II 123 bp markers 100 bp markers 
digested DNA digested DNA (BRL) (Pharmacia) 
markers markers 
(NEB) (NEB) 
23,130 bp 8,454 bp 1, 722 bp 1,400 bp 
9,416 bp 7,242 bp 1,599 bp 1,300 bp 
6,557 bp 6,369 bp 1,476 bp 1,200 bp 
4,361 bp 5,686 bp 1,353 bp 1,100 bp 
2,322 bp 4,822 bp 1,230 bp 1,000 bp 
2,027 bp 4,324 bp 1,107 bp 900 bp 
564 bp 3,675 bp 984 bp 800 bp 
125 bp 2,323 bp 861 bp 700 bp 
1,929 bp 738 bp 600 bp 
1,371 bp 615 bp 500 bp 
1,264 bp 492 bp 400 bp 
702 bp 369 bp 300 bp 
224 bp 246 bp 200 bp 
117 bp 123 bp 100 bp 











Molecular Studies on Chicken 
Growth Hormone Receptor 
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Chapter 3 Molecular Studies on Chicken Growth 
Hormone Receptor 
3.1 Introduction 
Chicken GHR cDNA was cloned by Bumside et al. (1991) using a 
standard library screening procedure. In our study, chicken GHR cDNA 
was amplified from the chicken first strand cDNA pool by PGR. The 
design of the 2 primers used in PGR is based on the reported chicken GHR 
cDNA sequence, flanking the coding region of the chicken GHR. Also a 
Nde I restriction site and a Bam HI restriction site are introduced near the 
5' end of the forward and the backward primer respectively in order to 
facilitate the subcloning of the cDNA into the pET 3a prokaryotic 
expression vector for prokaryotic expression. 
The PCR amplified chicken GHR cDNA was subcloned and partially 
sequenced in order to verify its identity. Then the cDNA was used as a 
probe in the study of the ontogeny of GHR mRNA expression in chicken 
liver and brain. This ontogeny study can provide us some information 
regarding the developmental regulation of chicken hepatic and brain GHR. 
The last part of this chapter deals with prokaryotic expression of chicken 
GHR in E. coli. The overexpressed protein can be used for generation of 
antibodies. These antibodies can be served as a tool for further 
characterization of GHR. 
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3.2 Materials and Methods 
3.2.1 Molecular Cloning of Chicken GHR cDNA by PCR 
3.2.1.1 Animals and Tissue 
New Hamshire chicken brains were provided by Dr. Karl Tsim, 
Department of Biology, The Hong Kong University of Science and 
Technology. After the birds were killed, the brains were frozen 
immediately in liquid nitrogen. The brains were then stored at -70^C until 
use. 
3.2.1.2 Reverse Transcribed-Polymerase Chain Reaction 
(RT-PCR) 
mRNA of chicken brain was isolated using the Quick Prep Micro mRNA 
Purification Kit (section 2.21) and then reverse transcribed to first strand 
cDNA by using the First Strand cDNA Synthesis Kit (section 2.22). Oligo 
d(T)i8 primer was used in reverse transcription. 
Chicken GHR cDNA was generated by PCR using chicken GHR primer 9 
and 10 (cGHRp9 & cGHRplO). Figure 3.1 shows the positions of the 
primers on chicken GHR cDNA, as well as their sequences.Chicken brain 
first strand cDNA was used as the template in PCR. PCR was performed 





Extracellular domiainl 1 Cytoplasmic domain 
5’ [ _ I 3, 
— • M-
cGHRp9 cGHRplO 
Figure 3.1. Diagrammatic represaitation of chicken GHR cDNA. The arrows indicate the 
position of cGHRp9 & cGHRplO on the cDNA. cGHRp9 5'-
TTAGACATATGGATCTTCGGCA3' and cGHRplO: 5'-TCAAAGGGATCCTACGGCATG 
ATTTTGTTCAGCTGGTCTGTGCTCACATAGCCAC-3'. The two primers flanking the 
coding region of chicken GHR cDNA. A Nde I site and a Bam HI site are introduced into 
cGHRp9 and cGHRplO respectively (underlined). 
The amplification process was carried out under following conditions in a 
thermocycler (TEMP.TRONIC, Thermolyne): 
Cycle Denaturation Annealing Polymerization 
1st to 32th 20 seconds 20 seconds 1.5 minutes 
cycle at 9 4 � � at 5 5 � � at 72^C 
33th cycle 20 seconds 20 seconds 10 minutes 
at 940c at 550c at 72^C ——.. 
3.2.1.3 Subcloning of PCR Amplified DNA Fragment. 
The 3' ragged ends of PCR amplified chicken GHR cDNA fragments were 
modified by the method as mentioned in section 2.23. Then the blunt-ended 
fragments were ligated to linearized pBluescript SK+ (Sma I digested) 
vector (section 2.25). 
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Then the ligated plasmid was transformed into E. coli strain DH5a (section 
2.6). The transformed cells were screened by rapid screening (section 2.7). 
Then the plasmid was isolated by Plasmid MiniPrep (section 2.3 and 2.4). 
The identity of the cloned fragments were verified by DNA sequencing 
(section 2.26). 
3.2.2 Ontogeny of GHR mRNA Expression in Chicken 
Liver and Brain 
3.2.2.1 Animals and Tissues 
New Hamshire chicken brains and livers at different developmental stages 
were again provided by Dr. Karl Tsiiri, Department of Biology, The Hong 
Kong University of Science and Technology. After the chickens were 
killed, the brains and livers were frozen in liquid nitrogen immediately. 
They were stored at -70^C before use. 
3.2.2.2 Northern Analysis 
Chicken GHR mRNA transcript was detected by Northern analysis. 
Chicken brain or liver total RNA was fractionated by： formaldehyde / 
agarose gel electrophoresis (section 2.9) and then was transferred to a 
Hybon-N nylon membrane by capillary transfer (2.16). 
Hybridization of RNA was performed by the method as mentioned in 
section 2.17 using [a32p]dCTP labeled chicken GHR cDNA as probe at 
550c^ 6X SSC. And the hybridized membrane was washed twice at 55^0, 
IX SSC. 
48 
3.2.2.3 Quantification of GHR mRNA Level 
The signals on the exposed X ray film and the intensity of ethidium 
bromide stained 28S ribosomal RNA were scanned into a computer by a 
scanner and then quantified by a computer program (ImageQuant 3.3, 
Molecular Dynamics). 
3.2.3 Prokaryotic Expression of Chicken GHR cDNA 
3.2.3.1 Subcloning of Chicken GHR cDNA into a 
Prokaryotic Expression Vector 
5 |Lig of chicken GHR cDNA containing SK+ plasmid was first completely 
digested with 50 units of Nde I (New England Biolab) at 370C. Due to the 
presence of Bam HI cutting site inside the extracellular domain of chicken 
GHR cDNA, the following procedure was adopted in order to obtain the 
full length chicken GHR cDNA. 
50 units of Bam HI (New England Biolab) was added to the Nde I digested 
plasmid and incubated at ST^C. One-fouith of the reaction mixture was 
� � 
pipetted out and transferred to a fresh eppendorf tube every 15 minutes 
and 1 |il of 0.5M EDTA was added immediately to each aliquot. Then the 
4 aliquots were pooled and analysed by agarose gel electrophoresis. The 
full length chicken GHR cDNA was isolated from the gel by the 
GENECLEAN procedure ( section 2.8) and then ligated to linearized 
pET3a ( digested by � I & Bam HI) (section 2.20). The ligated plasmid 
was transformed into E. coli strain DH5a. 
49 
The plasmid of the transformed cells was isolated by plasmid miniprep. 
DNA sequencing was then performed in order to determine whether the 
chicken GHR cDNA is in frame or not. 
3.2.3.2 Expression of Chicken GHR cDNA in E. coli 
pET3a vector containing chicken GHR cDNA was transformed into E. coli 
strain BL21 (DE3�pLysS). A single colony of the transformed cell was 
inoculated in 10 ml M9ZB with 50 lag/ml ampicillin and 25 |ig/ml 
chromophenical. The culture was allowed to grow at 37^C with vigorous 
shaking until ODgoO reached 0.8. The expression was then induced by 
adding IPTG to a final concentration of 0.4 mM. The culture was allowed 
to grow at 37OC for 3 more hours • During incubation, 1 ml culture was 
pipetted out at every hour after the addition of IPTG . The cell were 
collected by centrifugation at 12�000g for 2 minutes at room temperature in 
a microcentrifuge. The supernatant was discarded and the cells were 
resuspended in 400 2X SDS-PAGE loading buffer. The suspension was 
sonicated for 30 seconds at 15 |il of sonicated suspension was 
analysed by SDS-PAGE. 
3.2.1.3 SDS - Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
Mini-PROTEAN H electrophoresis cell (BioRad) was used for SDS-
PAGE. The cell was assembled based on the manufacturer's instruction. 
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12% SDS-polyacrylamide running gel solution was prepared as follows: 
Water 1.6ml 
l.SMTris (pH8.8) 1.3 ml 
30 % Acrylamide 2.0 ml 
10%(w/v) SDS 50 III 
10%(w/v) ammonium persulfate 50 |LI1 
TEMED (BioRad) 2 |il 
Running gel solution was poured into the gap between the glass plates to 
2/3 full. 1 ml isopropanol was then added on the top of the solution 
surface to remove air bubbles and to keep the solution away from 
atmospheric oxygen. The gel was allowed to polymerize for 30 minutes. 
After polymerization, isopropanol was discarded and the gap was rinsed 
with water and blotted dry with blotting paper. 
5% stacking gel solution was prepared as follows: 
Water 1.4 ml 
l.OMTris (pH6.8) 0.25 ml 
30 % Acrylamide 0.33 ml 
10%(w/v) SDS 20 i^l 
10%(w/v) ammonium persulfate 20 jil 
TEMED (BioRad) 2 
Stacking gel solution was poured on top of the running gel and the comb 
was inserted . The gel was allowed to polymerize for 15 minutes. 
I 
15 i^ l of sonicated sample was mixed with an equal volume of water and 
was boiled for 3 minutes. The boiled sample was then loaded into the well. 
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A constant current of 35 mA was applied. Electrophoresis was stopped 
when the bromophenol blue dye reached the bottom of the running gel. 
After electrophoresis, the gel was removed from the electrophoresis cell 
and was stained overnight with Commassie Brilliant Blue staining 
solution. After staining, the gel was destained by destaining solution. The 




3.2.4 Reagents and Buffers 
3.2.4.1 Medium for Bacterial Culture 
M9ZB medium 
NH4CI i g 




Make to 1 liter with distilled water, autoclaved at 121OC for 15 minutes. 
Just before use, the followings were added : 
20 ml 20% glucose (filter-sterilized) 
1 ml IM MgS04 (filter-sterilized) 
3.2.4.2 Reagents for SDS-PAGE 
2X SDS gel-loading buffer 
IM Tris (pH 8.0) 1ml 
10% SDS 4 ml 
Glycerol 2 ml 
Bromophenol blue 0.02g 
P-mercaptoethanol 0.2 ml 
Make to 10 ml with distilled water. 
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Staining solution 
Commassie brilliant blue 0.575g 
R-250 
Ethanol 1.25 ml 
Acetic acid 40 ml 
Make to 400 ml with distilled water. 
Destaining solution 
Ethanol 500 ml 
Acetic acid 160 ml 
Make to 2 liters with water. 
3-2.5 Size of Protein Molecular Weight Markers 
Low molecular weight protein markers (Pharmacia) 
Phosphorylase b 94,000 kDa 
Albumin 67,000 kDa 
Ovalbumin 43,000 kDa 
Carbonic anhydrase 30,000 kDa 
Trypsin inhibitor 20,100 k Da 
a-lactalbumin 14,400 kDa 
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3.3 Results 
3.3.1 Molecular Cloning of Chicken GHR cDNA by PCR 
3.3.1.1 RT-PCR 
Chicken GHR cDNA was amplified from chicken brain first strand cDNA 
using cGHRp9 & 10. Figure 3.2 shows the result of the PCR. A 1.8 kb 
fragment was obtained. The size of this fragment is similar to the reported 
chicken GHR. This fragment was named fragment cGHR. 
4 3 2 1 
； • 
Figure 3 2 Agarose gel analysis of PCR product amplified from chicken first strand cDNA. 
Lane 1. PCR using cGHRp 9 &10. Lane 2: \ BstE H marker. Lane 3: PCR positive^ntrol 
using Actm primers. Lane 4: PCR negative control using cGHRp 9 & 10 (no template added). 
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3.3.1.2 Subcloning 
Fragment cGHR was subcloned into pBluescript SK+ {Sma I digested) and 
transformed into E. coli strain DH5a. The transformed colonies were 
streaked onto LB ampicillin plate and labeled 1 to 25. The presence of an 
insert in the plasmid were analyzed by rapid screening. Figure 3.3 shows 
the result of the rapid screening . 
25 14 SK 5 3 
BitgtfflriffiM 
Figure 3.3. Rapid screwing to test for the presaice of insert in the transformants. Colonies 3，5， 
14 and 25 contain an insert. The SK lane of each panel is the intact pBluescript SK+. 
Colony number 5 and 14 were selected and grown in LB ampicillin 
medium. Their plasmids were isolated by mini-preparation. The size of the 
plasmids were analyzed by agarose gel electrophoresis (Figure 3.4). By 
comparing the size of plasmid with pBluescript SK+ plasmid, it was found 
that the plasmids from these colonies contain an insert. 
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Figure 3.4. Agarose gel analysis of isolated plasmid. Lane 1: plasmid from colony 5. Lane 2: 
plasmid from colony 14. Lane 3: X Hind HI digested marker. Lane 4: Intact pBluescript SK+. 
3.2.13 Nucleotide Sequence Analysis 
Colony 14 was selected and the identity of fragment cGHR was 
determined by DNA sequencing of its 5' and 3' end. In order to facilitate 
DNA sequencing, highly purified plasmid was isolated by Magic ™ 
Minipreps DNA Purification Kit. 
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After sequencing of cloned fragment (in plasmid of colony 14) it was found 




3.3.2 Ontogeny of GHR mRNA Expression in Chicken Liver 
and Brain 
The total RNA of chicken liver of different developmental stages were 
fractionated by formaldehyde / agrose gel (Figure 3.5) and then transferred 
to Hybon-N nylon membrane. The RNA was hybridized with [a32p]dCTP 
labeled chicken GHR cDNA overnight at 550C, 6X SSC. The hybridized 
membrane was washed twice at SS^C, IX SSC and exposed overnight to 
X-ray film. The autoradiograph was shown in Figure 3.6. 




Figure 3.5. Formaldyde / agrose gel analysis of chicken liver total RNA. Lane 1. 5 fog day 7 
chicken Uver total RNA. Lane 2. 5 i^g day 11 chicto liver total RNA. Lane 3. 5 ^g day 13 
diickea liver total RNA. Lane 4. 5 i^g day 16 chickai liver total RNA. Lane 5. 5 ^g day 19 
chicken liver total RNA. Lane 6. 5 ^g day 21 chick«i liver total RNA. Lane 7. 5 ^g day 35 
chicken liver total RNA. Lane 8. 5 ^g day 100 chicken liver total RNA. 
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Figure 3.6. Autoradiogtraph of the result of Northern analysis using [a^^P]dCTP labeled full 
length chickai GHR cDNA as probe. The lane numbers corresponds to those in Figure 3.5. 
I 
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The result of hepatic GHR mRNA expression is shown in Figure 3.7. The 
hepatic GHR mRNA level increased from day 7 to a maximum at day 13 
and then a drastic decrease was observed from day 19 to day 21. Then the 
mRNA was kept at a low level afterwards. 
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Figure 3.7. Ontogeny of chickoi hepatic GHR mRNA. H^atic GHR mRNA levels were 
determined by Northern blot hybridization analysis of RNA (compared to 28S rRNA) from 
chickai livers and expressed in arbitrary doisitomertic units (ADU). Day 1 to 20 is the 
embryonic stage. Hatching occurred at day 21. 
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The total RNA of chicken brain of different developmental stages were 
fractionated by formaldehyde / agrose gel (Figure 3.8) and then transferred 
to Hybon-N nylon membrane. The RNA was hybridized with [a32p]dCTP 
labeled chicken GHR cDNA overnight at 550C, 6X SSC. The hybridized 
membrane was washed twice at 55^0, IX SSC and exposed overnight to 
X-ray film. The autoradiograph was shown in Figure 3.9. 
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Figure 3.8. Formaldyde / agrose gel analysis of chickoi brain total RNA. Lane 1. 20 ^igday 11 
chicken brain total RNA. Lane 2. 20 ^g day 13 chicken brain total RNA. Lane 3. 20 \xg day 16 
c h i c k � brain total RNA. Lane 4. 20 ^g day 19 chickai brain total RNA. Lane 5. 20 ng day 
21 chicken brain total RNA. Lane 6. 20 ^g day 35 chicken brain total RNA. Lane 7. 20 |ig day 
100 diicken brain total RNA. 
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Figure 3.9. Autoradiogtraph of the result of Northern analysis using [a^^PJdCTP labeled full 
length diickai GHR cDNA as probe. The lane numbers corresponds to those in Figure 3.5. 
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The result of brain GHR mRNA expression is shown in Figure 3.10. The 
brain GHR mRNA was kept at a relatively constant level throughout the 
study. 
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Figure 3 10 Ontogaiy of chicken brain GHR mRNA. Brain GHR mRNA levels were 
determined by Northern blot hybridization analysis of RNA (compared to 28S rRNA) from 
chicken brains and expressed in arbitrary densitomertic units (ADU). Day 1 to 20 is the 
embryonic stage. Hatching occurred at day 21. 
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3.3.3 Prokaryotic Expression of Chicken GHR cDNA 
3.3.3.1 Subcloning 
Chicken GHR cDNA containing SK+ (pCGHR) was digested by Nde I and 
then partial digested by Bam HI. The 1.8 kb chicken GHR cDNA was 
released (Figure 3.11, Lane 4). The cDNA was subcloned into pET3a 
(digested by Bam HI and Nde I) and then transformed into E. coli strain 
DH5a. The transformed colonies were streaked onto LB ampicillin plate 
and labeled 1 to 50. 
6 5 4 3 2 1 
M _ 
I * 
T W e 3 11 Restriction digestion of chicken GHR cDNA containing SK+ plasmid (pCGHR). 
S ' i ^ L S S r . l L 2: pCGHR cUgest^ by Nde I. Lane 3: pCGHR cUge^ed by Bam 
m . Lane 4: pCGHR digested by Nde I and Bam HI. Lane 5: Intact pBluescnpt SK . Lane 6 : � 
Hind i n marker. 
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Colony number 11 and 12 were selected and grown in LB ampicillin 
medium. Their plasmids were isolated by mini-preparation. The size of the 
plasmids were analyzed by agarose gel electrophoresis (Figure 3.12). By 
comparing the size of plasmid with intact pET3a plasmid, it was found the 
plasmids from these colonies contain an insert. 
4 3 2 1 
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Figure 3.12. Agarose gel analysis of isolated plasmid. Lane 1: plasmid from colony 11. Lane 2: 
plasmid from colony 12. Lane 3: X Hind m marker. Lane 4: intact pET3a plasmid. 
3.3.3.2 Nucleotide Sequence Analysis 
Colony number 11 was selected for sequencing. The 5' and 3' ends of the 
subcloned fragment was sequenced. Start codon and stop codon were 
presented in the 5� and 3' end respectively (Figure 3.13). And the 
nucleotide sequence was identical to the reported chicken GHR cDNA. 
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Figure 3.13. DNA sequencing of plasmid from colony number 11. Panel A: Sequencing using 
pET forward primer, a start codon (ATG) was identified. Panel B : Sequencing using pET 
reverse primer, a stop codon (TAG) was identified. 
3.3.3.3 Prokaryotic Expression 
Chicken GHR cDNA containing pET3a plasmid was transformed into 
expression host E, coli strain BL21 (DE3 pLysS). IPTG was added to 
induce target protein expression in E. coli. Bacterial cells were collected 
� 
at different time after IPTG added and then lysed by sonication. The 
bacterial protein were analyzed by SDS-PAGE (Figure 3.14). It was found 
that no specific protein was expressed. 
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Figure 3.14. SDS-PAGE analysis of protein from E. coli strain BL21. Lane 1 to 4: Protein 
isolated from un-induced E. coli strain BL21 at time 1 , 2, 3 and 4 hour respectively. Lane 5: 
Low molecular weight marker (Pharmacia). Lane 6 to 9: Protein isolated from IPTG induced E. 
coli strain BL21 at time 1 , 2, 3 and 4 hour respectively. 
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3.4 Discussion 
3.4.1 Molecular Cloning of Chicken GHR cDNA by PCR 
In this part of the study, chicken GHR cDNA was amplified from the 
chicken brain first strand cDNA pool. According to the protocol used in 
this study, the first step was isolation of RNA from chicken brain. This 
RNA isolation step is very essential because if the RNA is degraded, the 
first strand cDNA synthesized from the degraded RNA may only contain a 
few copy of intact target gene. It is difficult to amplified it from the cDNA 
pool. 
The preparation of high quality RNA from tissue is usually hindered by the 
presence of active ribonucleases (RNases). RNases are a family of 
enzymes that degrade RNA molecules through both endonucleolytic and 
exonucleolytic activity. These enzymes are very stable and their tertiary 
structure are maintained by four disulfide bridge (Blackburn & Moore� 
1982) that allow these enzymes to renature quickly, following treatment 
with most denaturants or even after boiling. RNases have minimal cofactor 
requirements and are active over a wide pH range (Farrell, 1993). 
In order to isolate fuU length, intrinsically liable RNA, RNase activity 
should be controlled. Accidental introduction of RNase from contaminated 
glassware and solutions is a major problem during RNA, extraction. 
Therefore all the glassware were baked at 1 8 0 � � f o r overnight because 
high temperature can denature the RNases. And the solutions were treated 
with 0.1% DEPC which is a strong RNases inhibitor 
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Apart from the exogenous contamination of RNases, the tissue itself 
contains RNases. One way to get intact RNA is to denature all cellular 
proteins including RNases. Guanidinium thiocyanate extraction method 
was employed. In this method, the lysis buffer contains a strong protein 
denaturant called guanidinium thiocyanate (Chirgwin et al., 1979). It is an 
excellent inhibitor of RNase activity during purification of RNA from cells 
and whole tissue samples. In addition, a reductant called p-
mercaptoethanol was added which can break the protein disulfide bonds 
and these bonds are essential for the RNase activity. 
And finally the quality of the isolated RNA was determined by 
spectrophotometry. The mRNA preparation with OD26O 丨 OD280 ratio 
higher than 1.8 was used in the first strand cDNA synthesis. And the 
cDNA was used as template in PCR. 
PGR is a powerfiil technique in biological researches. In this study it was 
frequently employed. The chicken GHR cDNA was amplified from the first 
strand cDNA pool. Although the cDNA was amplified, it could not be 
subcloned into the blunt-end vector. It is because thermostable DNA 
polymerase possess a template-independent polymerization activity that 
adds a single dATP to the 3� ends of PCR products (Clark, 1988). These 
extra nucleotides will hinder the subcloning of the amplified DNA into a 
blunt-end vector. Therefore these nucleotides should be removed before 
subcloning. In this study, the PCR amplified DNA fragments were 
modified by DNA polymerase 1. The 3，� 5，exonuclease activity of DNA 
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polymerase I can remove single-base 3' overhangs on PGR amplified 
fragments (Starr and Quaranta, 1992). 
3.4.2 Ontogeny of GHR mRNA Expression in Chicken 
Liver and Brain 
The aim of this study is to investigate the ontogenty of expression of GHR 
mRNA in chicken liver and brain. Chicken GHR mRNA was detected in 
both brain and liver at all the stages studied. It was found that GHR 
mRNA in liver was much higher than that in brain. This observation is 
similar to that in some mammals (Mathews, 1989; Kelly et al.’ 1991). The 
hepatic GHR mRNA level was maintained at a relatively high level before 
hatching but just before hatching (at day 19) a drastic decrease was 
observed. After hatching the mRNA level was kept at a very low level. 
This result was agreed with the hepatic GHR binding assay (Vanderpooten 
et al., 1991). This means that the hepatic GHR binding decreases before 
hatching is due to the depression of GHR mRNA expression. The sudden 
decrease of the hepatic GHR level may be due to the high circulating GH 
concentration at the time of hatching (Harvey et al； 1979; Vanderpooten et 
al., 1991). The increase in GH concentration is possibly due to the 
maturation of GH secretory cells in the pituitary (Harvery et al, 1979). In 
mammals, GH up-regulates hepatic GHR level (Baxter & Zaltsman^ 1984; 
Orian et al； 1991; Vikman et al., 1991). But in chicken GH down 
regulates hepatic GH-binding activity (Vanderpooten et aL, 1991). 
Circulating GH concentration in the domestic fowl are elevated at time of 
hatching. The GH increases may depress the hepatic GHR mRNA 
expression. 
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The chicken brain GHR mRNA level was kept at a relatively constant level 
in all stages. The elevation of circulating GH before hatching seem to have 
no direct effect on the brain GHR mRNA expression. This may be due to 
the fact that GH cannot pass through the blood-brain barrier (Lawrence et 
al., 1982). 
3.4.3 Prokaryotic Expression of Chicken GHR cDNA 
Prokaryotic expression of a specific protein is a useful technique in 
biological research because the expressed protein can be used in rising 
antibody. The antibody can be used for immimoblotting to detect the 
expression of the protein in different parts of the tissue. Also it can be used 
for protein purification. Finally it can serve as probe in cDNA library 
screening. 
In this study chicken GHR cDNA was subcloned into a prokaryotic 
expression vector (pET 3a) in order to express the receptor protein in E. 
coli stain BL21 (DE3 pLysS). The pET system is a powerful system for 
the cloning and expression of recombinant proteins in E. coli. Target genes 
are cloned in pET plasmids under control of strong bacteriophage T7 
transcription signals; expression is induced by providing a source of T7 
RNA polymerase in the host cell. T7 RNA polymerase is so selective and 
active that almost all the ceU's resources are converted to target gene 
expression. Another important benefit of this system is its ability to 
maintain target genes transcriptionally silent in the uninduced state; in host 
strains containing a pLysS plasmid that provides a small amount of T7 
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lysozyme. The T7 lysozyme serve as a natural inhibitor of T7 RNA 
polymerase, it stabilizes target plasmids by decreasing the basal activity of 
T7 RNA polymerase, but it does not prevent induction of high levels of 
target proteins. 
Although the chicken GHR cDNA was successfully amplified from the 
first strand cDNA and subcloned, the expression was seem to be failed. 
This phenomenon was also observed for some other eukaiyotic proteins 
(Studier et al； 1990). In this study the cDNA was obtained by PCR, 
therefore there is a possibility that a mis-incorporation of nucleotide during 
PCR might have occurred, introducing a termination codon inside the 
cDNA. Later it was found that this is not the reason because the cDNA 
was successfully expressed in an eiikaryotic system (293 cells) exhibiting 
GH binding activity (personal commimication, data not shown). 
In some study, the target protein itself may interfere with gene expression 
in the prokaryotic expression system especially some toxic proteins. Rapid 
decrease in the rate of protein synthesis as target protein accumulates, or 
sometimes all protein synthesis stops before any target protein can be 
detected ( Studier et al., 1990). 
Instability of target mRNA might affect the target protein expression. The 
stability of mRNA in the pET system depends on the stem-and-loop 
structures at both ends ofRNAs that are initiated at the usual (|)10 promoter 
and tenninated at 1(|)； or the mRNA may be inaccessible to exonucleases 
by being embedded in the long RNAs produced by T7 RNA polymerase in 
the absence of T(|) transcription termination signal (Studier et al, 1990). In 
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the pET3a vector T . transcription termination signal is present therefore 
the mRNA is not protected by embedding in long RNAs. The mRNA 
stability in our system seems to be maintained by the stem-and-loop 
structure. This stem-and-loop structure may be ineffective in the protection 
of the chicken GHR mRNA. 
Although E. coli strain BL21 is apparently deficient in the Ion and ompT 
proteases and many proteins produced in this strain are quite stable, 
instability of certain target proteins were also observed (Studier et al” 
1990). The reason for the degradation of target protein is still unknown. In 
our expression experiment, it is difficult to verify whether degradation of 
the target jprotein was occured or not. It is because no negative control, the 
protein isolated from the untransformed E. coli strain BL21, was added 
during SDS-PAGE analysis. In order to determine whether the target 
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4.1 Introduction 
The present study aimed to clone the pigeon GHR cDNA by PCR. In the 
study, the pigeon GHR cDNA was cloned by employing three different 
PCR techniques - the main core PCR, the 5，AmpliFINDER RACE and the 
random initiated RNA-PCR. 
Chicken GHR cDNA and the mammalian GHR cDNAs so far cloned share 
approximately 70% overall homology. It is believed that pigeon GHR 
cDNA should have certain degree of homology to the reported GHR 
cDNAs. Therefore chicken GHR primer 9 and 10 were used in the main 
core PCR in order to amplified the main core of the pigeon GHR cDNA 
from the pigeon liver first strand cDNA pool. 
After the main core PCR, the 5� AmpliFINDER RACE and the random 
initiated RNA-PCR were performed in order to determine the exact 
sequences of the main core of the pigeon GHR cDNA covered by chicken 
GHR primer 9 and 10, as well as of the 5, and 3' end sequences. 
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4.2 Materials and Methods 
4.2.1 Animals and Tissues 
Adult female pigeons (Columba livid) were purchased from a local market 
at Shatin and was transported alive to the laboratory. After the birds were 
killed, the livers were dissected out and then frozen in liquid nitrogen 
immediately. The livers were stored at -70^C before use. 
4.2.2 Cloning of Pigeon GHR cDNA Main Core by PCR 
4.2.2.1 RT-PCR 
mRNA of pigeon liver was isolated using the Quick Prep Micro mRNA 
Purification Kit (section 2.21) and then reverse transcribed to first strand 
cDNA using the First Strand cDNA Synthesis Kit (section 2.22). Oligo 
d(T)i8 primer was used in reverse transcription. 
Pigeon liver first strand cDNA was used as template in PCR using chicken 
GHR primer 9 and 10 (cGHRp9 & cGHRplO). Figure 3.1 shows the 
positions of the primers on chicken GHR cDNA, as well as their 
sequences. 
PCR was performed by the method as described in section 2.23 with 
modification as follows : 
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Cycle Denaturation Annealing Polymerization 
1st to 32th 20 seconds at 20 seconds at 1.5 minutes at 
cycle 940c 55QC 720C 
33th cycle 20 seconds at 20 seconds at 10 minutes at 
940c 550c 720C 
4.2.2.2 Southern Analysis of PCR Amplified Product 
After the PCR amplified products were separated by agarose gel 
electrophoresis, the DNA inside the gel was transferred to a Hybon-N 
nylon membrane (Amersham) by capillary transfer (section 2.16). Full 
length chicken GHR cDNA was used as probe for hybridization. The 
cDNA was released from the plasmid by restriction digestion with 
appropriate restriction enzymes (Eag I and EcoRV) (section 2.10) and was 
then labeled with [a32p]dCTP (section 2.14). 
Hybridization was performed as described in section 2.17. 
4.2.2.3 Subcloning of PCR Amplified DNA Fragment 
The PCR amplified pigeon GHR cDNA fragment was cloned by the 
procedure described in section 3.2.1.3 and the identity of the fragment was 
verified by DNA sequencing(section 2.26). 
4.2.3 Determination of 3, End Coding Sequence of Pigeon 
GHR cDNA 
The 3' end coding sequence of pigeon GHR cDNA was determined by 
random primer initiated RNA-PCR (Fritz et aL, 1991). Pigeon liver mRNA 
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was reverse transcribed to first strand cDNA by the First Strand cDNA 
Synthesis Kit ( section 2.22) using a primer containing a random hexamer 
at its 3' end (Figure 4.1). 5 |il of first strand cDNA reaction mixture was 
used as template in the first PCR. 
First PCR was performed by the method as mentioned in section 2.18 using 
pigeon GHR specific primer 1 (pgGHRspl) and primer Y (Figure 4.1). 
The First PCR amplified product was purified by GENECLEAN ( section 
2.12). 5 |il purified product was used as template in the second PCR using 
pigeon GHR specific primer 2 (pgGHRsp2) and primer X (Figure 4.1). 
The second PCR product was analyzed by agarose gel electrophoresis. 
The band containing the desired DNA was isolated ( section 2.12) and was 
cloned to linearized pBluescript SK+ by the method mentioned in section 
3.2.1.3. The identity of the fragment was verified by DNA sequencing ( 
section 2.26). 
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pgGHRspl pnmerY 
First PCR 
V primer X 
First PCR — — — - — — — NNNNNN 
product NNNNNN — — 
^ pgGHRsp2 
Second PCR 
Second PCR NNNNNN 
product — — — — — NNNNNN — 
Figure 4.1. Diagrammatic rq)resentation of the random primer initiated RNA-PCR method. 
First strand cDNA is initiated by using RT primer. First PCR is performed by using primer Y 
& pgGHRspl. Second PCR is performed by using primer X & pgGHRsp2. The primer 
sequences are listed below. 
RT primer :5'- CGAGGGGGATGGTCGACGGAAGCGACCNNNNNN -3•，N=A, T，C or G 
Primer Y : 5,- CGAGGGGGATGGTCGACGG -3' 
Primer pgGHRspl : 5�-CTACTTCTGTGAGGCAGATG -3 
Primer X : 5’- GATGGTCGACGGAAGCGACC-3' 
Primer pgGHRsp2 : 5�-CGCACTGCCTOTGCCTGACAAGOAATTCAA -3'. 
pgGHRspl is located at position 1521 to 1542 of fragment M and pgGHRsp2 is located at 
position 1762 to 1792 of fragmait M (Figure 4.9). The distance betweoi Pnmer pgGHsp 1 and 
pgGHRsp2 is 220 nucleotides. 
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4.2.4 Determination of 5' End Coding Sequence of Pigeon 
GHR cDNA 
The 5� end coding sequence of pigeon GHR cDNA was determined using 
the 5’ AmpliFINDER ™ R A C E Kit (Clontech). This is a PCR-based 
cDNA cloning method. In this method direct ligation of a specially 
designed "anchor" oligonucleotide to the 3'-end of the first strand cDNA 
was carried out by T4 RNA ligase and PCR was then performed using 
complementary "anchor�� primer and a gene-specific primer. 
The following procedure is based on the method recommended by the 
supplier. 2 |Lig of pigeon liver mRNA was dissolved in 9 jil DEPC-treated 
water and mixed with 1 pi of 10 [xM pigeon GHR specific primer 3 
solution (pgGHRspS) (Figure 4.2). The mixture was denatured at 65^C for 
5 minutes. After denaturation, 9.2 |il DEPC-treated water, 9 [xl 4X Reverse 
Transcription Buffer, 1.6 jil RNase Inhibitor (40 imits/jal), 3.7 }il Ultrapiire 
dNTP Mix (lOmM for each nucleotide) and 12.5 units of AMV reverse 
transcriptase were added. The mixture was incubated at 52^C. After 30 
minutes 1 |il of 0.5 M EDTA was added to stop the reaction. Then 2 |il of 
6N NaOH was added to the mixture and incubated at 65^C for 30 minute 
to hydrolyze the RNA. After RNA hydrolysis, 2 \xl 6N acetic acid was 
added to neutralize the NaOH. 
80 i^l of 6M sodium iodide and 8 |al GENO-BIND ™ suspension were 
added to the cDNA reaction mixture. The mixture was kept on ice for 10 
minutes with occasional shaking. The mixture was then centrifuged in a 
microcentrifuge at 12,000g for 10 seconds. The supernatant was discarded 
and the pellet was washed with 500 t^l of 80% ethanol. The suspension 
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was centrifuged again. The washing procedure was repeated one more 
time. The washed pellet was air dried for 5 minutes and then resuspended 
in 50 |al of DEPC-treated water. After incubation at 65^0 for 5 minutes, 
the suspension was centrifuged in a microcentrifuge at 12,000g for 2 
minutes and the supernatant containing the cDNA was collected. The 
cDNA was then precipitated by ethanol precipitation (section 2.1) and 
finally dissolved in 6 jliI DEPC-treated water. 
2.5 of the cDNA, 2 lal of AmpliFINDER anchor (4 pmol) (Figure 4.2), 
5 |il of 2X Single-Stranded Ligation Buffer and 10 units of T4 RNA Ligase 
were mixed for anchor-ligation. The mixture was kept at 16®C for 22 
hours. 
After the AmpliFINDER anchor ligation, 1 |il of anchor-ligated cDNA was 
used as template for PGR using pigeon GHR specific primer 4 
(pgGHRsp4) and AmpliFINDER anchor primer (section 2.23) (Figure 4.2). 
The PGR product was analyzed by agarose gel electrophoresis. The band 
containing the desired DNA was isolated ( section 2.12) and was cloned to 
linearized pBluescript SK+ by the method mentioned in section 3.2.1.3. 
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Figure 4.2. Diagrammatic repres^tation of AmpliFINDER RACE method. First strand cDNA 
is initiated by using primer pgGHRspS. AmpliFINDER anchor is ligated to the first strand cDNA. 
PCR is carried out using AmpliFINDER anchor primer & pgGHRsp4. The primer sequences are 
listed below. 
Primer pgGHRspS : 5'- T G T A T T G T T C C T G G A G C A C T G A G G T T -3. 
AmpliFINDER anchor : 5'- CACGAATTCACTATCGAITCTGGAACCTTCAGAGG-NHs -3 
AmpliFINDER anchor primer : 5'-CTGGTTCGG€CCACCTCTGAAGGTTCCAGAATCGA 
TAG-3 ' . 
Primer pgGHRsp4 : 5'- CCGTCAGTCCAATAACATGAAAACGT -3'. 
pgGHRspS is located at position 164 to 190 of fragment M and pgGHRsp4 is located at position 
129 to 154 of fragment M (Figure 4.9). 
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4.3 Results 
4.3.1 Cloning of Pigeon GHR cDNA Main Core by PCR 
43.1.1 RT-PCR 
PCR was carried out by using chicken GHR cGHRp9 and cGHRplO. 
Pigeon liver first strand cDNA was used as template. Figure 4.3 shows 
the result of the PCR. A DNA fragment of about 1.8 kb, which is of the 
expected size, was obtained (Lane 1). This fragment was named as 
fragment M. 
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Figure 4 3 Agarose gel analysis of PCR product amplified from pigeon liver first strand 
eDNA Lane 1. PCR using cGHRp 9 &10. Lane 2: \ BstE U marker. Lane 3: PCR positive 
二 us"g a 1 pnmefs. L = 4 : PCR negative control usmg cGHRp 9 & 10 (no pigeon 
liver first strand cDNA added). 
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4.3.1.2 Southern Analysis 
The 1.8 kb DNA fragment (fragment M) in the gel was transferred to a 
nylon membrane and hybridized with [a32p]dCTP labeled Ml length 
chicken GHR cDNA at 550C, 6X SSC and was then washed at 550C, 
0.5X SSC. A signal was detected by autoradiography after overnight 
exposure and the position of the signal corresponds to the position of 
fragment M on the membrane (Figure 4.4). 
1 
M l [ • • • • J 
Figure 4.4. Southern analysis of PCR products from pigeon liver first strand cDNA using 
[a32p]dCTP labeled chicken GHR cDNA as probe. The lane numbers correspond to those in 
Figure 4.3. 
4.3.1.3 Subcloning of Fragment M 
Fragment M was subcloned into pBluescript SK+ (Sma I digested) and 
transformed into E, coli strain DH5a. The transformed colonies were 
streaked onto LB ampicillin plate and labeled 1 to 50. The presence of an 
insert in the plasmid were analyzed by rapid screening. Figure 4.5 shows 
the result of rapid screening . 
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Figure 4.5. Rapid screening to test for the presence of insert in the transformants. Colonies 2, 
20，22, 30, 31, 34，36，43，46 contain an insert. The SK lane of each panel is the intact 
pBluescript SK+. 
Colony number 2, 20 and 22 were selected and grown in LB ampicillin 
medium. Their plasmids were isolated by mini-preparation. The size of the 
plasmids were analyzed by agarose gel electrophoresis (Figure 4.6). By 
comparing the size of plasmid with pBluescript SK+ plasmid, it was found 
the plasmids from these colonies contain an insert. 
Figure 4.6. Agarose gel analysis of isolated plasmid. Lane 1: plasn^d from colony 2. Lane2: 
plasmid from colony 20. Lane 3: X Hind III digested marker. Lane 4: Intact pBluescnpt SK 
Lane 5: plasmid from colony 22. 
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4.3.1.4 Restriction Digestion of the Plasmid 
In order to confirm the 1.8 kb fragment M was inserted into the vector, 
plasmids from colony number 2, 20 and 22 were digested with Eag I and 
EcoR V which are located in the polycloning site of pBluescript SK+ and 
flanking fragment M. Figure 4.7 shows that a 1.8 kb fragment was released 
from the plasmid of colonies 2 and 20 (Lane 1 & 2) after digestion. 
Plasmid of colony 22 (Lane 3) did not release any fragment. Therefore 
colonies 2 and 20 were further processed. 
I 5 4 3 2 1 
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Figure 4.7. Restriction digestion of plasmid. Lane 1: colony 2 plasmid ^gested by Eag I & 
E^R V Lane 2: colony 20 plasmid digested by Eag I & EcoR V. Lane 3: colony 22 plasimd 
f 二 by Eag I & EcoR V. Lane 4: Intact pBluescnpt SK+. Lane 5: X BstE U digested 
marker. 
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4.3.1.5 Nucleotide Sequence Analysis 
Colony 2 and 20 were selected and the identity of fragment M was 
determined by DNA sequencing. In order to facilitate DNA sequencing, 
highly purified plasmid was isolated by the Magic ™ Minipreps DNA 
Purification Kit. 
The sequencing strategy is shown in Figure 4.8 and the nucleotide 
sequence of fragment M was presented in Figure 4.9. 
5, Fragment ；M of" pigeon GHR. cDNA 3. 
Seq 1 • 
Seq 2 • 
Seq 6 
Seq 3 • 
Seq 7 
Seq 8 
Seq 4 • 
^ Seq 9 
^ Seq 10 
^ Seq 11 
Seq 5 • 
^ Seq 12 
Figure 4.8 . The sequoicing s trat � y of fragment M was subcloned in pBluescript SK+ 
The sequoicing primers are numbered and their sequences are listed below. 
Seq 1 :AACAGCTATGACCATG 
Seq 2 : AGGTATGGATCTTCGGCATCTGCT 
Seq 3 : GTTTCAGTGTTGATGAAA 
Seq 4 : CCAGTTCCAAAGATTAAAGG 
Seq 5 : CTACITCTGTGAGTCAGATG 
Seq 6 : CATCCTTTCTGAACATCTGC 
Seq 7 : CCTTTAATCTTTGGAACTGG 
Seq 8 :TAAACTCAACCCATAAG 
Seq 9 : CTGOTCAAGGCACAAGAGA 
Seq 10�• TCTGTGCTCACATAGCCAC 
Seq 11 : TCAAAGGGATCCTACG 
Seq 12 :GTAAAACGACGGCCAGT 
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5' 1 TTAGACATAT GGATCTTCGG CATCTGCTGC TTACTTTGGT GCTGGTCTGT GCAAATGACT 
61 CACTTTCTGC AAGTGATGAT GTTTTGCGAT TGCCACAAAT CAGCAAGTGC AGATCACCTG 
121 AACTGGAGAC GTTTTCATGT TATTGGACTG ACGGAAATTT TTATAACCTC AGTGCTCCAG 
181 GAACAATACA ACTATTGTAC ATGAAAAGGA ATGATGAAGA CTGGAAAGAA TGTCCTGATT 
2 4 1 ATATCACTGC AGGAGAAAAC AGCTGTTATT TCAACACGTC CTACACCTCT ATTTGGATAC 
3 0 1 CATATTGTGT TAAGCTTGTC AATAAAGATG AAGTATTTGA TGAAAAATGT TTCAGCGTTG 
3 6 1 ATGAAATAGT ACTACCTGAC CCCCCTGTCC ATCTTAACTG GACTCTGCTA AATACTAGTC 
4 2 1 AAACTGGGAT CCATGGGGAT ATTCAAGTAA GATGGGATCC GCCACCAACA GCAGATGTTC 
4 8 1 AGAAGGGATG GATTACTCTG GAGTATGAAT TGCAGTACAA AGAAGTTAAT GAGACAAAAT 
541 GGAAGGAGTT AGAACCCAGG CTCTCAACAA TGGTTCCACT GTACTCTCTG AAGATAGGAA 
6 0 1 GAGATTATGA GATACGAGTC CGATCAAGAC AACGTACCTC TGAAAAATTT GGGGAGTTCA 
661 GTGAAATCCT TTATGTATCT TTTTCTCAAG CGGGCATTGA ATTTGTTCAT TGTGCTGAAG 
7 2 1 AAATTGAGTT TCCATGGTTC TTAGTTGTTA TCTTCGGAGC ATGTGGTCTG GCCGTAACAG 
7 8 1 TGATCTTAAT CCTGCTGTCT AAACAATCGA GGTTAAAAAT GCTGATTTTT CCTCCTGTGC 
8 4 1 CAGTTCCAAA GATTAAAGGG ATTGACCCAG ATCTTTTGAA GAAAGGAAAG CTAGATGAAG 
901 TTAACTCCAT CTTAGCCAGT CATGACAATT ACAAGACACA GCTGTACAAT GACGACTTAT 
961 GGGTTGAGTT TATTGAATTG GACATAGAAG ACCCCGATGA AAAGAACAGA GTCTCAGATA 
1 0 2 1 CTGACAGGCT CCTGAGTGAA GACCATCTGA AATCACACAG TTGCTTGGGA GCGAAGGATG 
1 0 8 1 ATGATTCTGG ACGTGCCAGT TGCTGTGAAC CAGATATTCC AGAGACAGAC TTCAGTGCAA 
1 1 4 1 GCGACACATG CGATGCCATC TCTGATATTG ATCAGTTCAA AAAGGTAACT GAAAAAGAAG 
12 01 AGGATCTCTT GTGCCTTGGT AGAAAAGATA ATGATGAGTC ACTTCCAAGC CTTGCCAACA 
1 2 6 1 CAGACACCCA ACAGCCGCGT ATGAGTACTC GACCCGAAAA TAGCCAGCCA TGGCCACCTT 
1 3 2 1 TTGCAGACAG CATTGACGCA GCTAGTCCAT CGGCCCATAA CCAGCTGAGT AACCAGAATT 
1 3 8 1 CATTGAGAAA TACTGACTTT TACGCGCAAG TGAGTGATAT TACCCCAGCA GGCAGTGTTG 
1441 TGCTTTCACC AGGGCAGAAA TCCAAGGTGG CGAGAGCACG GTGTGAATTC TGCACAGAAC 
1 5 0 1 AAAACTTCAC CCTGGACAAT GCCTACTTCT GTGAGGCAGA TGTGAAAAAA TGTATTGCTG 
1 5 6 1 TGATTTCCCA CGAAGAGGAT GAGCCACGTG TTCAGGCGCA AATCTGTAAC GAGGACACTT 
1 6 2 1 ACTTCACCAC AGAAAGCCTT ACCACTACTG GCATCAGTCT TGGAGCTTCA ACAGCAGAAA 
1 6 8 1 CCCCAAGTCC AGAGGTGCCT GTCCCAGACT ACACGTCTAT TCATATCGTC CACTCTCCAC 
1741 AAGGCCTTGT GCTCAACGCA ACCGCACTGC CTGTGCCTGA CAAGGAATTC AACATGTCTT 
1 8 0 1 GTGGCTATGT GAGCACAGAC CAGCTGAACA AAATCATGCC GTAGCCCTTT QA 3' 
Figure 4.9. The nucleotide sequence of fragment M of pigeon GHR cDNA. 
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4.3.2 Determination of 3' End and 5, End Coding Sequences 
of Pigeon GHR cDNA 
The main core of pigeon GHR cDNA was amplified by using cGHRp9 and 
cGHRplO. In order to obtain the complete pigeon GHR cDNA sequence, 
the 3' and 5’ end coding sequences should be determined, including the 
exact sequence of the regions covered by the PCR primers, which 
represent chicken sequences instead of pigeon sequences. 
4.3.2.1 Random Primer Initiated RNA-PCR 
The 3' end coding sequence of pigeon GHR cDNA was determined by the 
method of random primer initiated RNA-PCR. A DNA fragment of 0.7 kb 
was amplified in the first PCR using pgGHRspl and primer Y (Figure 
4.10, Lane 3). 
The first PCR products served as template for the second PCR using 
pgGHRsp2 and primer X. A DNA fragment of 0.45 kb was obtained 
(Figure 4.10, Lane 4). The molecular weight difference between the first 
PCR and the second PCR product is about 0.25 kb. This molecular weight 
difference is similar to the distance between pgGHRspl and pgGHRsp2 
(0.2 kb). Therefore this 0.45 kb fragment was further processed and was 
named as fragment 3'. 
4.3.2.2 AmpliFINDER RACE 
The 5, end coding sequence of pigeon GHR cDNA was determined by the 
AmpliFINDER RACE method. AmpliFINDER anchor ligated cDNA 
served as template for PCR using pgGHRsp4 and AmpliFINDER pnmer. 
8S 
A DNA fragment of 0.3 kb was obtained (Figure 4.11, Lane 1). This 0.3 kb 
fragment was named as fragment 5'. 
j 
Figure 4.10. Agarose gel analysis of random primer initiated RNA-PCR products amplified 
from pigeon first strand cDNA. Lane 1: X BstE U digested marker. Lane 2: 100 bp marker. 
Lane 3: First PCR using pgGHRsp 1 & primer Y. Lane 4: Second PCR using pgGHRspl & 
primer X. Lane 5: First PCR negative control. Lane 6: Second PCR negative control. 
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Figure 4 11� Agarose gel analysis of AmpliFINDER RACE PCR product from pigeon fim 
s t L d cDNA. Lane 1: PCR using primer pgGHRsp4 and AmpliFINDER pnmer. Lane 2: X 
Hind m digested marker. Lane 3: PCR negative control (no template added). 
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4.3.2.3 Subcloning of Fragment 3, and Fragment 5， 
Fragment 3' and fragment 5' were subcloned in pBluescript SK+ and 
transformed into E, coli strain DH5a. The transformants were streaked 
onto LB ampicillin plate and labeled 3'(1) to 3�(18) (for fragment 3') and 
5'(1) to 5'(25) (for fragment 5'). The presence of an insert in the plasmids 
were analyzed by rapid screening (Figure 4.12). 
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Figure 4.12. Rapid screening to test for the presence of insert in the transformants. 
Panel A: 
C d ^ 3'(3), (7)，(8), (9)，（10)，（11)，（12)，（15) contain an insert. 
Panel B: 
Colonies 5丨(10)，(12), (13)，（15)，（20)，(23) contain an msert. 
The SK lane of each panel is the intact pBluescnpt SK . 
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Colonies 3’(3), 3'(7)，5'(15), 5’(20) and 5,(23) were selected and plasmids 
were prepared from them. By comparing the size of plasmids with 
pBluescript SK+, it was found that the plasmids from these colonies 
contain an insert (Figure 4.13). 
4 3 2 1 
4 3 2 1 
• • 
• 面 
Figure 4.13. Agarose gel analysis of isolated plasmids. 
Panel A* 
Lane 1: Intact pBluescript SK+. Lane 2: X Hind m marker. Lane 3: Colony 3'(3) plasmid. Lane 
4: Colony 3�(7) plasmid. . 
S ^ I n t a c t pBluescript SK+. Lane 2: Colony 5'(15) plasmid. Lane 3: Colony 5'(20) plasmid. 
Lane 4: Colony 5'(23) plasmid. 
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4.3.2.4 Nucleotide Sequence Analysis 
Colony 3�(7) and 5�(15) were selected for DNA sequencing. Fragment 3’ 
was sequenced by employing universal and reverse sequencing primers. 
Fragment 5� was sequenced by employing reverse sequencing primer. The 
nucleotide sequence of fragment 3' (partial sequence only) and fragment 5' 
(complete sequence) are presented in Figure 4.14 and Figure 4.15 
respectively. The partial sequence of fragment 3' and the complete 
sequence of fragment 5’ covered the 3' and 5' end sequence of pigeon GHR 
cDNA and enable us to construct the whole coding cDNA sequence of 
pigeon GHR. 
5' 1 CACTGCCTGT GCCTGACAAG GAATTCAACA TGTCTTGTGG CTACGTGAGC ACAGACCAGC 
61 TGAACAAAAT CATGCCATAG CTCTTCTTTG ACTAGGTGTG TGTAGTATTT CACAGCAGAG 
121 TCAGCTTGGG TTGTATGCTG AAACCAAAAT GAAGTCTGAA AGTTTCTCGT GGTTCTTATA 
181 A 3‘ 
Figure 4.14. The partial nucleotide sequence of fragment 3'. 
5 • 1 CTGGTTCGGC CCACCTCTGA AGGTTCCAGA ATCGATAGTG AATTCGTGAA ATGACTCACT 
61 TTCTGCAAGT GATGAATTAG AGGTATGGAT CTTCGGCATC TGCTGCTTAC TTTGGTGCTG 
121 GTCTGTGCAA ATGACTCACT TTCTGCAAGT GATGATGTTT TGCGATTGCC ACAAATCAGC 
181 AAGTGCAGAT CACCTGAACT GGAGACGTTT TCATGTTATT GGACTGACG 3, 
Figure 4.15. The complete nucleotide sequence of fragment 5'. 
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4.3.3 Nucleotide Sequence and Predicted Amino Acid 
Sequence of Pigeon GHR 
The nucleotide sequence and predicted amino acid sequence are presented 
in Figure 4.16. From the nucleotide sequence, a single ATG (start codon) is 
identified starting at position 47 downstream of the beginning of the 
sequence. A TAG (stop codon) is found starting at position 1880. 
The pigeon GHR cDNA encodes a single open reading frame (ORF) of 
612 amino acids. The amino acid sequence and nucleotide sequence of 
pigeon GHR are compared with several reported GHR cDNA sequences 
by a computer software called DNASIS. Table 4.1 summarizes the result 
of nucleotide and amino acids homology search. The alignment of 
predicted amino acid sequence of the pigeon, chicken and several 
mammalian GHR are shown in Figure 4.17. 
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1 T GAA TTC GTG AAA TGA CTC ACT TTC TGC AAG TGA TGA ATT 4 0 
1 Met Asp Leu Arg His Leu Leu Leu Thr Leu Val Leu 12 
41 AGA GGT ATG GAT CTT CGG CAT CTG CTG CTT ACT TTG GTG CTG 82 
13 Val Cys Ala Asn Asp Ser Leu Ser Ala Ser Asp Asp Val Leu 26 
83 GTC TGT GCA AAT GAC TCA CTT TCT GCA AGT GAT GAT GTT TTG 124 
27 Arg Leu Pro Gin lie Ser Lys Cys Arg Ser Pro Glu Leu Glu 40 
125 CGA TTG CCA CAA ATC AGC AAG TGC AGA TCA CCT GAA CTG GAG 166 • 
41 Thr Phe Ser Cys Tyr Trp Thr Asp Gly Asn Phe Tyr Asn Leu 54 
167 ACG TTT TCA TGT TAT TGG ACT GAC GGA AAT TTT TAT AAC CTC 2 08 
55 Ser Ala Pro Gly Thr lie Gin Leu Leu Tyr Met Lys Arg Asn 68 
209 AGT GCT CCA GGA ACA ATA CAA CTA TTG TAG ATG AAA AGG AAT 25 0 
� 69 Asp Glu Asp Trp Lys Glu Cys Pro Asp Tyr lie Thr Ala Gly 82 
251 GAT GAA GAC TGG AAA GAA TGT CCT GAT TAT ATC ACT GCA GGA 292 
� 
83 Glu Asn Ser Cys Tyr Phe Asn Thr Ser Tyr Thr Ser lie Trp 96 
2 93 GAA AAC AGC TGT TAT TTC AAC ACG TCC TAG ACC TCT ATT TGG 334 
97 lie Pro Tyr Cys Val Lys Leu Val Asn Lys Asp Glu Val Phe 110 
335 ATA CCA TAT TGT GTT AAG CTT GTC AAT AAA GAT GAA GTA TTT 376 
. � 
111 Asp Glu Lys Cys Phe Ser Val Asp Glu lie Val Leu Pro Asp 124 
377 GAT GAA AAA TGT TTC AGC GTT GAT GAA ATA GTA CTA CCT GAC 418 
125 Pro Pro Val His Leu Asn Trp Thr Leu Leu Asn Thr Ser Gin 138 
419 CCC CCT GTC CAT CTT AAC TGG ACT CTG CTA AAT ACT AGT CAA 460 
139 Thr Gly lie His Gly Asp lie Gin Val Arg Trp Asp Pro Pro 152 
461 ACT GGG ATC CAT GGG GAT ATT CAA GTA AGA TGG GAT CCG CCA 502 
153 Pro Thr Ala Asp Val Gin Lys Gly Trp lie Thr Leu Glu Tyr 166 
503 CCA ACA GCA GAT GTT CAG AAG GGA TGG ATT ACT CTG GAG TAT 544 
167 Glu Leu Gin Tyr Lys Glu Val Asn Glu TlXX Lys Trp Lys Glu 180 
545 GAA TTG CAG TAG AAA GAA GTT AAT GAG ACA AAA TGG AAG GAG 586 
181 Leu Glu Pro Arg Leu Ser Thr Met Val Pro Leu Tyr Ser Leu 194 
587 TTA GAA CCC AGG CTC TCA ACA ATG GTT CCA CTG TAG TCT CTG 62 8 
195 Lys H e Gly Arg Asp Tyr Glu lie Arg Val Arg Ser Arg Gin 208 
629 AAG ATA GGA AGA GAT TAT GAG ATA CGA GTC CGA TCA AGA CAA 670 
209 Arg Thr Ser Glu Lys Phe Gly Glu Phe Ser Glu lie Leu Tyr 222 
671 CGT ACC TCT GAA AAA TTT GGG GAG TTC AGT GAA ATC CTT TAT 712 • , 
223 Val Ser Phe Ser Gin Ala Gly lie Glu Phe Val His Cys Ala 236 
713 GTA TCT TTT TCT CAA GCG GGC ATT GAA TTT GTT CAT TGT GCT 754 
237 Glu Glu lie Glu iPhe Pro Trp Phe Leu Val Val lie Phe Gly 250 
755 GAA GAA ATT GAG ITTT CCA TGG TTC TTA GTT GTT ATC TTC GGA 796 
251 Ala Cys Qly Leu Ala Val Thr Val lie Leu lie Leu Leu seri 264 
797 aCA TGT GCT CTG GCC GTA ACA GTG ATC TTA ATC CTG CTG TCTI 838 
94 
265 Lys Gin Ser Arg Leu Lys Met Leu H e Phe Pro Pro Val Pro 278 
83 9 AAA CAA TCG AGG TTA AAA ATG CTG ATT TTT CCT CCT GTG CCA 880 
279 Val Pro Lys lie Lys Gly lie Asp Pro Asp Leu Leu Lys Lys 292 
881 GTT CCA AAG ATT AAA GGG ATT GAC CCA GAT CTT TTG AAG AAA 92 2 
293 Gly Lys Leu Asp Glu Val Asn Ser H e Leu Ala Ser His Asp 306 
923 GGA AAG CTA GAT GAA GTT AAC TCC ATC TTA GCC AGT CAT GAC 964 
307 Asn Tyr Lys Thr Gin Leu Tyr Asn Asp Asp Leu Trp Val Glu 320 
965 AAT TAG AAG ACA CAG CTG TAG AAT GAC GAC TTA TGG GTT GAG 1006 
321 Phe lie Glu Leu Asp lie Glu Asp Pro Asp Glu Lys Asn Arg 334 
1007 TTT ATT GAA TTG GAC ATA GAA GAC CCC GAT GAA AAG AAC AGA 1048 
335 Val Ser Asp Thr Asp Arg Leu Leu Ser Glu Asp His Leu Lys 348 
1049 GTC TCA GAT ACT GAC AGG CTC CTG AGT GAA GAC CAT CTG AAA 1090 
349 Ser His Ser Cys Leu Gly Ala Lys Asp Asp Asp Ser Gly Arg 362 
1091 TCA CAC AGT TGC TTG GGA GCG AAG GAT GAT GAT TCT GGA CGT 113 2 
363 Ala Ser Cys Cys Glu Pro Asp lie Pro Glu Thr Asp Phe Ser 376 
1133 GCC AGT TGC TGT GAA CCA GAT ATT CCA GAG ACA GAC TTC AGT 1174 
377 Ala Ser Asp Thr Cys Asp Ala lie Ser Asp lie Asp Gin Phe 390 
1175 GCA AGC GAC ACA TGC GAT GCC ATC TCT GAT ATT GAT CAG TTC 1216 
391 Lys Lys Val Thr Glu Lys Glu Glu Asp Leu Leu Cys Leu Gly 404 
1217 AAA AAG GTA ACT GAA AAA GAA GAG GAT CTC TTG TGC CTT GGT 1258 
405 Arg Lys Asp Asn Asp Glu Ser Leu Pro Ser Leu Ala Asn Thr 418 
125 9 AGA AAA GAT AAT GAT GAG TCA CTT CCA AGC CTT GCC AAC ACA 13 00 
4 1 9 Asp Thr Gin Gin Pro Arg Met Ser Thr Arg Pro Glu Asn Ser 432 
13 01 GAC ACC CAA CAG CCG CGT ATG AGT ACT CGA CCC GAA AAT AGC 1342 
4 3 3 Gin Pro Trp Pro Pro Phe Ala Asp Ser lie Asp Ala Ala Ser 446 
1343 CAG CCA TGG CCA CCT TTT GCA GAC AGC ATT GAC GCA GCT AGT 1384 
447 Pro Ser Ala His Asn Gin Leu Ser Asn Gin Asn Ser Leu Arg 460 
1385 CCA TCG GCC CAT AAC CAG CTG AGT^AAC CAG AAT TCA TTG AGA 1426 
461 Asn Thr Asp Phe Tyr Ala Gin Val Ser Asp lie Thr Pro Ala 474 
1427 AAT ACT GAC TTT TAG GCG CAA GTG AGT GAT ATT ACC CCA GCA 1468 
475 Gly Ser Val Val Leu Ser Pro Gly Gin Lys Ser Lys Val Ala 488 
1:69 GGC AGT GTT GTG CTT TCA CCA GGG CAG AAA TCC AAG GTG GCG 1510 
489 Arq Ala Arg Cys Glu Phe Cys Thr Glu Gin Asn Phe Thr Leu 502 
^tll ill Gcl CGS TGT GAA TTC TGC ACA GAA CAA AAC TTC ACC CTG 1552 
i 
ASD Asn Ala Tyr Phe Cys Glu Ala Asp Val Lys Lys Cys lie 516 
TAG H T GCC TIC TTC TGT GAG GCA GAT GTG AAA AAA TGT ATT 1594 
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545 Thr Thr Thr Gly lie Ser Leu Gly Ala Ser Thr Ala Glu Thr 558 
1679 ACC ACT ACT GGC ATC AGT CTT GGA GCT TCA ACA GCA GAA ACC 172 0 
559 Pro Ser Pro Glu Val Pro Val Pro Asp Tyr Thr Ser lie His 572 
17 21 CCA AGT CCA GAG GTG CCT GTC CCA GAC TAG ACG TCT ATT CAT 1762 
573 lie Val His Ser Pro Gin Gly Leu Val Leu Asn Ala Thr Ala 586 
1763 ATC GTC CAC TCT CCA CAA GGC CTT GTG CTC AAC GCA ACC GCA 1804 
587 Leu Pro Val Pro Asp Lys Glu Phe Asn Met Ser Cys Gly Tyr 600 
1805 CTG CCT GTG CCT GAC AAG GAA TTC AAC ATG TCT TGT GGC TAG 1846 
601 Val Ser Thr Asp Gin Leu Asn Lys lie Met Pro *** 612 
1847 GTG AGC ACA GAC CAG CTG AAC AAA ATC ATG CCA TAG CTC TTC 1888 
1889 TTT GAC TAG GTG TGT GTA GTA TTT CAC AGC AGA GTC AGC TTG 1930 
1931 GGT TGT ATG CTG AAA CCA AAA TGA AGT CTG AAA GTT TCT CGT 1972 
1973 GGT TCT TAT AA 1983 
Figure 4.16. The nucleotide sequence and predicted amino acid sequence of pigeon GHR. 
Amino acids are numbered from the 5'- most ATG, and the in phase stop codon is denoted by 
three asterisks. The putative transmembrane domain is boxed. The conserved cysteine residues 




Organism Nucleotide Amino Acid 
Sequence Sequence 
Chicken 90.2 % 89.3 % 
Human 66.6 % 60.6 % 
Porcine 65.2 % 62.3 % 
Sheep 52.7 % 60.3 % 
Rat 68.3 % 55.6 % 
Mouse 66.0 % 55.5 % 
Table 4.1. Nucleotide (ORF) and amino acid sequences homology search between pigeon GHR 
and other reported GHRs. 
@ * 
Pigeon MDLRHLLLTL ALVCANDSLS ASDDVLRLPQ IS KCRSPE 
Chicken MDLRHLLFTL ALVCANDSIS ASDDLLQWPQ IS KCRSPE 
Rat MDLWRVFLTL ALAVSSDMFP GSGATPATLG KASPVLQRIN PSLRESSSGK PRFTKCRSPE 
Rabbit MDLWQLLLTV ALAGSSDAFS GSEATPATLG RASESVQRVH PGLGTNSSGK PKFTKCRSPE 
Human MDLWQKLLTL ALAGSSDAFS GSEATAAILS RAPWSLQSVN PGLKTNSSKE PKFTKCRSPE * * * @ 
Pigeon LETFSCYWTD C3NFYNLSAPG TIQLLYMKRN DED WKECPDYITA GENSCYFNTS 
Chicken LETFSCYWTD GKVTTS---G TIQLLYMKRS DED WKECPDYITA GENSCYFNTS 
Rat LETFSCYWTE GDDHNL---K VPGSIQLYYA RRIAHEWTPE WKECPDYVSA GANSCYFNSS 
Rabbit LETFSCHWTD GVHHGL---K SPGSVQLFYI RRNTQEWTQE WKECPDYVSA GENSCYFNSS 
Human RETFSCHWTD EVHHGT---K NLGPIQLFYT RRNTQEWTQE WKECPDYVSA GENSCYFNSS * * @ @ 
Pigeon YTSIWIPYCV KLVNKDEVFD EKCFSVDEIV LPDPPVHLNW TLLNTSQTGI HGDIQVRWDP 
Chicken YTSIWIPYCV KLANKDEVFD EKCFSVDEIV LPDPPVHLNW TLLNTSQTGI HGDIQVRWDP 
Rat YTSIWIPYCI KLTTNGDLLD EKCFTVDEIV QPDPPIGLNW TLLNISLPGI RGDIQVSWQP 
Rabbit YTSIWIPYCI KLTNNGGMVD QKCFSVEEIV QPDPPIGLNW TLLNVSLTGI HADTQVRWQP 
Human FTSIWIPYCI KLTSNGGTVD EKCFSVDEIV QPDPPIALNW TLLNVSLTGI HADTQVRWEA 
Pigeon P P T A D V Q K G W I T L E Y E L Q Y K E V n I t K W K E L E P R L S T M V P L Y S L K I G R D Y E IRVRSRQRTS 
Chicken PPTADVQKGW ITLEYELQYK EVNETKWKEL EPRLSTWPL YSLKMGRDYE IRVRSRQRTS, 
Rat PPSADVLKGW IILEYEIQYK EVNETKWKTM SPIWSTSVPL YSLRLDKEHE VRVRSRQRSF 
Rabbit PPNADVQKGW IVLEYELQYK EVNETQWKMM DPVLSTSVPV VSLRLDKEYE VRVRSRQRSS 
Human�PPNADIQKGW MVLEYELQYK EVNETKWKMM DPILTTSVPV VSLKVDKEYE VRVRSKQRNS 
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* 
Pigeon EKFGEFSEIL YVSFSQAGIE FVHCAEEIEp- PWFLWIFGA CGLAVTVILI LLskQSRLKM 
Chicken EKFGEFSEIL YVSFTQAGIE FVHCAEEIE? PWFLVWFGV CGLAVTAILI LLSKQPRLKM 
Rat EKYSEFSEVL RVTFPQMDTL AA-CEEDFR? PWFLIIIFGI FGVAVMLFW IFSKQQRIKM 
Rabbit EKYGEFSEVL YVTLPQMSPF T--CEEDFR?* PWFLIIIFGI FGLTVMLFVF IFSKQQRIKM 
Human GNYGEFSEVL YVTLPQMSQF T--CEEDFY?' PWLLIIIFGI FGLTVMLFVF LFSKQQRIKM 
Pigeon LIFPPVPVPK IKGIDPDLLK KGKLDEVNSI LASHDNYKTQ LYNDDLWVEF lELDIEDPDE 
Chicken LIFPPVPVPK IKGIDPDLLK KGKLDEVNSI LASHDNYKTQ LYNDDLWVEF lELDIDDSDE 
Rat LILPPVPVPK IKGIDPDLLK EGKLEEVNTI LGIHDNYKPD FYNDDSWVEF lELDIDDADE 
Rabbit LILPPVPVPK IKGIDPDLLK EGKLEEVNTI LAIQDSYKPE FYNDDSWVEF lELDIDDPDE 
Human LILPPVPVPK IKGIDPDLLK EGKLEEVNTI LAIHDSYKPE FHSDDSWVEF lELDIDEPDE 
Pigeon KNRVSDTDRL LSEDHLKSHS CLGAKDDDSG RASCCEPDIP ETDFSASDTC DAISDIDQFK 
Chicken KNRVSDTDRL LSDDHLKSHS CLGAKDDDSG RASCYEPDIP ETDFSASDTC DAISDIDQFK 
Rat KTEESDTDRL LSDDQEKSAG ILGAKDDDSG RTSCYDPDIL DTDFHTSDMC DGTSEFAQPQ 
Rabbit KTEGSDTDRL LNSDHQKSLS VLAAKDDDSG RTSCYEPDIL ENDFNASDGC DGNSEVAQPQ 
Human KTEESDTDRL LSSDHEKSHS NLGVKDGDSG RTSCCEPDIL ETDFNANDIH EGTSEVAQPQ 
Pigeon KVTEKEEDLL CLGRKDNDE LPSLANTDTQ QPRMSTRPEN SQPWPPFADS IDAASPSAHN 
Chicken KVTEKEEDLL CLHRKDDVEA LQSLANTDTQ QPHTSTQSES RESWPPFADS TDSANPSVQT 
Rat KL-KAEADLL CLDQKNLKNS PY-DASIGSL HPSITLTMED KPQPLLGSET ESTHQLPST-
Rabbit RL-KGEADLL CLDQKNQNNS PY-DVSPAVQ QPEWLAEED KPRPLLTGEI ESTLQAAPS-
Human RL-KGEADLL CLDQKNQNNS PY-DACPATQ QPSVIQAEKN KPQPLPTEGA ESTHQAAHI-
Pigeon QLSNQNSLRN TDFYAQVSDI TPAGSWLSP GQKSKVARAR CEF C TEQNFTLDNA 
Chicken QLSNQNSLTN TDFYAQVSDI TPAGSWLSP GQKSKVGRAQ CES C TEQNETMDNA 
Rat PMSSPVSIiAN IDFYAQVSDI TPAGGWLSP GQLILAGLAQ GNTQLEVAAP CQENYSMNSA 
Rabbit QLSNPNSLAN IDFYAQVSDI TPAGGWLSP GQKNKAGNSQ CDAHPEWSL CQTNFIMDNA 
Human QLSNPSSLSN IDFYAQVSDI TPAGSWLSP GQKNKAGMSQ CDMHPEMVSL CQENFLMDNA 
Pigeon YFCEADVKKC lAVISHEEDE PRVQAQICNE DTYFTTESLT TTGISLGAST AETPSPEVPV 
Chicken YFCEADVKKC lAVISQEEDE PRVQEQSCNE DTYFTTESLT TTGINLGASM AETPSMEMPV 
Rat YFCESDAKKC lAAAPHMEAT TCVKPSFNQE DIYITTESLT TTARMSETAD TAPDAE--PV 
Rabbit YFCEADAKKC lAVAPHVDVW SRVEPSFNQE DTYITTESLT TTAERSGTAE DAPGS-EMPV 
Human YFCEADAKKC IPVAPHIKVE SHIQPSLNQE DTYITTESLT TAAGRPGTGE HVPGS-EMPV 
Pigeon PDYTSIHIVH SPQGLVLNAT ALPVPDKE-F NMSCGYVSTD QLNKIMP 
Chicken PDYTSIHIVH SPQGLVLNAT ALPVPEKE-F NMSCGYVSTD QLNKIMP 
Rat PDYTTVHTVK SPRGLILNAT ALPLPDKKKF LSSCGYVSTD QLNKIMQ 
Rabbit PDYTSIHLVK SPQGLVLNAA TLPLPDKE-F LSSCGYVSTD QLNKILP 
Human PDYTSIHIVQ SPQGLILNAT ALPLPDKE-F LSSCGYVSTD QLNKIMP 
Figure 4 17 Alignment of predicted amino acid sequence of the pigeon，chicken and 
mammalian GHRs. The putative transmembrane domains are boxed. The conserved cysteine 
residues in the extracellular domain are marked (*) and the potential N-glycosylation sites 
are marked 
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Hydropathy plot (Kyte & Doolittle, 1982) of the predicted ammo acid 
sequence of pigeon GHR is shown in Figure 4.18. One major hydrophobic 
region was detected at amino acids 241 to 264, presumably representing 
the transmembrane domain. 
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In the present study, pigeon GHR cDNA was cloned by PCR. This strategy 
was also employed in the cloning of porcine GHR cDNA (CiofFi et al., 
1990). Although PCR cloning is a powerful technique, it suffers from 
several drawbacks. One of which is that the exact sequences covered by 
the PCR primers are not known. In the porcine GHR sequence, the PCR 
primers design were based on the other reported GHR cDNA sequences. 
Therefore the 5’ and 3' end sequences (within the protein coding sequence) 
are not the exact sequence of porcine GHR. In order to overcome this 
drawback. Rapid Amplification of cDNA End (RACE) method was 
employed in the present study. 
The RACE method was first described by Frohman et al (1988) and 
Belyavsky et al (1989). The most important use of RACE is for 
amplification and cloning the 5' and 3' ends of incomplete cDNAs. In the 
present study, two modified RACE methods were employed, random 
initiated RNA-PCR and 5' AmpliFINDER RACE. These methods were 
employed to determine the sequence covered by the PCR primers as well 
as the 5' and 3' sequences. 
Random primer initiated RNA-PCR is modified from the original 3' RACE 
method. In this method, the first strand cDNA is synthesized in the 
presence of a RT primer containing a random hexamer at its 3' end instead 
of 3� Oligo(dT) containing RT primer in the original 3� RACE method. In 
the original method, the RT primer would bind to the poly A tail of mRNA 
during first strand cDNA synthesis. And the target sequence is amplified 
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from the cDNA pool by a gene specific primer and the primer 
complementary to the RT primer. In some instances, the 3' untranslated 
region of the target gene is very long. It is difficult to amplify the target 
sequence from the cDNA pool. The random primer initiated RNA-PCR 
method bears an advantage over the original 3' RACE method in that the 
random hexamer region of the RT primer can bind to different regions of 
the 3' untranslated sequence of the target gene. Therefore the first strand 
cDNA will become shorter. It is generally easier to amplify a short DNA 
fragment than a long one. 
In our preliminary studies, both the original and the modified 3' RACE 
method had been used. It was found that the target sequence could not be 
amplified using the original method. In some reported GHR's, their 3' 
untranslated region are about 2.5 kb in size. The failure of the original 
RACE method may be due to the 3' untranslated region of pigeon GHR 
mRNA being very long. 
The 5，cDNA end was cloned using the 5' AmpliFINDER RACE method-
a modified 5' RACE method. In the original 5' RACE method a 
homopolymeric tail of dA is added to the 3' end of the first strand cDNA 
using terminal deoxyribonucloetide transferase (Frohman et al., 1988). 
But this is a difficult reaction to optimize and to control (Siebert & Apte， 
1993). Furthermore Oligo(dT) primer is one of the PGR primers, therefore 
the specificity of PGR will decrease thus generating a high background of 
non-specific PGR product (Siebert & Apte，1993). In the present study, the 
employed 5' AmpliFINDER RACE method can overcome these 
drawbacks. This method involves ligation of a single-stranded 
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oligonucleotide anchor directly to the 3' end of the first strand cDNA by T4 
RNA ligase. And one of the PCR primers is complementary to the 
oligonucleotide anchor and the other is a gene specific one, therefore the 
specificity of PCR can be enhanced. 
After the main core PCR, random initiated RNA-PCR and 5' 
AmpliFINDER RACE were performed, three pigeon GHR cDNA 
fragments (fragment M, fragment 3' and fragment 5') were obtained. These 
three fragments were subcloned and sequenced. The combined nucleotide 
sequence of the three clones and the predicted amino acid sequence are 
shown in Figure 4.16. Both the nucleotide and amino acid sequences bear a 
high homology to chicken GHR (Table 4.1). The cDNA contains an open 
reading frame encoding 612 amino acids. The number of amino acid 
residues is similar to the reported GHR's from a number of animals , 
characterized by molecular cloning (Leung et al., 1987; Mathews et cd., 
1989; Smith et al., 1989; Adams et aL, 1990; Hauser et al., 1990; 
Bumside et al., 1991). The signal peptide of the pigeon GHR is likely to be 
the first 16 N-terminal amino acids because these 16 amino acids process 
the features of a typical signal sequence -- hydrophobic amino acids 
flanked by charged residues (Perlman & Halvorson^ 1983). GHR is a 
transmembrane protein, therefore a hydrophobic region inside the receptor 
protein is required for its insertion into the lipid bilayer of the cell 
membrane. From the hydropathy plot, only one major hydrophobic region 
of 24 amino acid residues is located in the protein molecule at. position of 
241 to 264. This is presumably the transmembrane domain which separates 
the extarceUular amino-temiiiial GH binding domain from the intraceUular 
carboxy terminal signaling domain. 
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A comparison of the nucleotide sequence and amino acid sequence 
between pigeon GHR and the other known GHR sequences were 
performed. It was found that both the nucleotide and amino acid sequences 
of pigeon and chicken GHR's are highly conserved (90.2 % and 89.3 % 
homology, respectively). This is not the case when pigeon GHR is 
compared with mammalian GHR's. Nucleotide and amino acid sequence 
homology between pigeon and mammalian GHR's is only about 65 % and 
60% respectively. Among mammalian GHR's themselves, sequence 
homology is very high. This result clearly indicates that GHR is highly 
conserved within the same class of animals. Sequence homology dropped 
between different classes of animal 
In the extracellular domain of pigeon GHR, there are five potential N-
glycosylation sites (Asn-X-Ser/Thr) (Figure 4.16). Four of them are 
conserved in all reported GHRs. 
Apart from the glycosylation sites, within the extracellular domain there are 
seven cysteines which appear to be conserved in both mammals, chicken 
and pigeon. These cysteine residues appear to be essential for stabilizing 
the folding of the extracellular domain through disulphide linkages. Due to 
the presence of conserved cysteine residues, it is believed that a similar 
tertiary structure exits for the GH-binding region in mammaUan, chicken 
and pigeon GHRs. This observation is in line with experimental results that 
Ugand—recognition by GHR does not exhibit high species specificity. 
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Hauser et al (1990) reported that the amino acid homology of GHR 
across mammalian species tends to be higher in the intracellular domain of 
the protein compared to the extracellular domain. They suggested that the 
conserved intracellular domain sequences may represent regions of the 
receptor that interact with other intracellular proteins as part of the signal 
transduction cascade. In the present study we found that the extracellular 
domain of pigeon GHR seems to be more conserved than the intracellular 
domain when compared with chicken and mammalian GHRs. This is also 
the case in chicken. Bumside et al (1991) reported that the role of the 
GHR in growth regulation in chickens could be fundamentally different 
from that in mammals because different physiological responses were 
observed after GH administration in chickens when compared with 
mammals. Therefore the signal transduction cascade in avian GHR might 
differ substantially from the mammalian GHR. 
Based on the results of our study, some fiiture investigations on pigeon 
GHR could be carried out. The cDNA can be used as a probe in Northern 
analysis of pigeon liver mRNA to determine transcriptional control and to 
detect whether GHR isoform(s) exist. It is known that in some animals at 
least two types of GHR exists, the transmembrane GHR and the serum 
GHBP (Leung et aL, 1987; Smith & Talamantes, 1987; Baumbach et al, 
1989). 
Another possibility that developmental study of pigeon GHR mRNA 
expression in different tissues can be done in order to determine the role of 
GHR in these tissues at different stages. 
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As mentioned before there is a possibility that some differences present in 
the signal transduction cascade in avian GHR as compared to mammalian 
GHR. Furthermore the signal transduction mechanism of GH is still 
unclear. Therefore the pigeon GHR cDNA can be used as a tool for the 
establishment of in vitro system to study the mechanism of GH signaling in 
pigeon and also to investigate the differences between mammalian and 
avian GH signaling. This could entail transfection studies coupled with 
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Chapter 5 Attempts on Molecular Cloning of 
Fish Growth Hormone Receptor 
Complementary DNA 
5.1 Introduction 
Hepatic GHR was characterized by binding studies in several species of 
fish (Hirano, 1991; Ng et aL, 1991; Mori et al., 1992; Ng et al., 1992). 
The present study is a preliminary study on cloning of the Dace (Cirrhinus 
molitorelld) GHR cDNA. Two common molecular biology techniques 
were employed in the present study ~ PCR and Northern analysis. 
Four pairs of PCR primers were designed with an aim to amplify 
fragtnent(s) of Dace GHR cDNA from the Dace liver first strand cDNA 
pool. Primers GHRpl and GHRp2 flank the region of GHR cDNA 
encoding the anterior part of the cytoplasmic domain. Primers GHRp3 and 
GHRp4 flank the posterior part of the cytoplasmic domain. Primers 
GHRp5 and GHRp6 flank the anterior part of the extracelluar domain. 
Primer GHRp7 & GHRp8 flank the posterior part of the extracellular 
domain and the transmembrane domain. 
Heterologous probe were frequently employed in cDNA library screening. 
In another part of this study, Ml length chicken GHR cDNA was labeled 
and hybridized with Dace RNA to test whether this heterologous probe can 
be used to screen the fish GHR. 
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5.2 Materials and Methods 
5.2.1 Animals and Tissues 
Adult Daces were purchased from a local market at Shatin and was 
transported alive to the laboratory. After the fish were killed, livers were 
dissected out and frozen in liquid nitrogen immediately. The livers were 
then stored at -70^C until use. 
5.2.2 Design of PCR primers 
The overall strategy to clone the Dace GHR cDNA is to use 
oligonucleotides as primers in PCR to generate DNA fragment(s) that 
could be used as probes to screen a Dace cDNA library. Nucleotide 
sequence comparison among the reported GHR sequences reveals 8 
possible primers. The sequences and the positions of the primers on GHR 
cDNA are shown in table 5.1. In addition, the suitability of these primers 
has been checked in two respects : 
1. against the gene bank data for homology with other protein to minimize 
the chance of false positive. 
2. against the software Primer Detective (Clontech) for the stability of 
these primers 
Furthermore, the expected PCR products would be around a few hundred 
bp long. These are good sized probed for subsequent hybridization in 
screening the cDNA library. 
I 
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Designation Sequence Position on GHR 
cDNA (using rat 
GHR as reference) 
GHRpl 5'- CCAGTTCCAAAGATTAAAGG - 3, 1097 to 1117 
GHRp2 5_- CTGGTCAAGGCACAAGAGA -3' 1458 to 1478 
GHRp3 5'> CTACTTCTGTGAGTCAGATG -3' 1789 tO 1809 
GHRp4 TCTGTGCTCACATAGCCAC -3' 2064 tO 2083 
GHRp5 5'- AGGTATGGATCTTCGGCATCTGCT -3' 251 to 275 
GHRp6 5'- CATCCTTTCTGAACATCTGC -3' 731 tO 750 
GHRp7 5'- GTTTCAGTGTTGATGAAA -3' 609 tO 626 
GHRp8 5'- CCTTTAATCnTGGAACTGG -3' 1097 to 1117 
Table 5.1. The sequences of GHR primers and their positions on rat GHR cDNA. 
5.2.3 RT-PCR and Subcloning ofPCR Amplified DNA 
mRNA of Dace liver was isolated using the Quick Prep Micro mRNA 
Purification Kit (section 2.21) and then reverse transcribed to first strand 
cDNA using the First Strand cDNA Synthesis Kit (section 2.22). Oligo 
d(T)i8 primer was used in reverse transcription. 
Dace liver first strand cDNA was used as template in PGR using GHR 
primer 1 to 8 (GHRpl to p8). Figure 5.1 shows the position of the primers 




Extracellular domai^ f^^ Cytoplasmic domain 
1 • I 3’ 
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GHRp5 GHRp6 i , _ _ _ 1 
app. 500 nts 
GHRp7 GHRp8 
‘ — — I — — ‘ 
app. 510 nts 
• M— 
GHRpl GHRp2 
‘ 1 “ " " “ ‘ 
app. 380 nts 
GHRp3 GHRp4 
app. 290 nts 
Figure 5.1 Diagrammatic representation of GHR cDNA. The arrows indicate the position of 
GHR primers on the cDNA and the length of the sequaices flanking by the primers are shown. 
Four PCRs are performed by using GHRpl & GHRpl，GHRp3 & GHRp4，GHRp5 & GHRp6 
and GHRp7 & GHRp8. 
The 3' ragged ends of PCR amplified DNA fragments were modified by the 
method as mentioned in section 2.23. Then the blunt-ended fragments were 
ligated to linearized pBluescript SK+ ( Sma I digested) vector (section 
2.24) 
Then the ligated plasmid was transformed into E. coli strain DH5a (section 
2.6). The transformed cells were screened by rapid screening (section 2.7). 
The plasmid was then isolated by Plasmid MiniPrep (section 2.3 and 2.4). 
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The identities of the cloned fragments were verified by DNA sequencing 
(section 2.25). 
5.2.4 Northern Analysis of Dace Liver RNA 
Total RNA and mRNA of Dace liver were isolated ( section 2.21 & section 
2.20). The RNA was then fractionated by formaldehyde / agarose gel 
electrophoresis (section 2.9). RNA in the gel was transferred to a Hybon-N 
nylon membrane (section 2.16) and was then hybridized with 
[a32p](iCTP labeled chicken GHR cDNA fragments. After hybridization, 






Two DNA fragments were amplified from Dace first strand cDNA • A 0.4 
kb DNA fragment was amplified using primers GHRpl and GHRp2 and 
the other DNA fragment with molecular size about 0.55 kb was amplified 
using primers GHRp5 and GHRp6 (Figure 5.2) The 0.4 kb and 0.55 kb 
fragments were named as Fragment A and Fragment B respectively. 
5 4 3 2 1 
I F ^ ^ 
I K A ^ i i i 
Figure 5 2 Agarose gel analysis of PCR products amplified from Dace first' strand cDNA. 
Lane 1' � l Bind IE marker. Lane 2: PCR using p r i m e r s GHRpl & GHRp2. Lane 3: PCRi^mg 
primers GHRp3 & 0 � 4 . Lane 4: PCR using primers GHI^5 & GHRp6. Lane 5: PCR 
using primers GHRp7 & GHRpS. 
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5.3.2 Subcloning 
Fragments A and B were subcloned in pBluescript SK+ {Sma I digested) 
and transformed into E, coli strain DH5a. The transformed colonies were 
streaked onto LB ampicillin plate and labeled Al to A24 ( Fragment A), 
B1 to B29 (Fragment B). 
The presence of insert in the plasmid of the bacterial colonies were 
analyzed by rapid screening (section 2.7). Figure 5.3 shown the result of 
the rapid screening. 
A H H l l i g 
I 
Figure 5 3 Rapid screening to test for the presence of insert in the transformants. Panel A: 
Colonic All，A12, A13 and A16 contain an insert. Panel B^ Colonies B1 to B29 contain an 
insert. The SK lane of eadi panel is the intact pBluescript SK . 
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A l l , A12，A13，B13, B15 and B20 were selected and grown m LB 
ampicillin medium. Their plasmids were isolated by mini-preparation 
(section 2.3). The size of the plasmids were analyzed by agarose gel 
electrophoresis (Figure 5.4). By comparing the size of the plasmids from 
Al, Bl, CI and D1 with pBluescript SK+ plasmid, it was found that the 
plasmid from these colonies contains an insert. 
5 4 3 2 1 
t 5 4 3 2 1 
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Figure 5.4. Agarose gel analysis of isolated plasmid. 
Pond A. 
Lane 1: plasmid from A l l . Lane 2: plasmid from A12. Lane 3: Plasmid from A13. Lane 4: X 
Hind i n digested marker. Lane 5: Intact pBluescript SK+. 
Panel B. 
Lane 1: plasmid from B13. Lane 2: plasmid from B15+Lane 3: Plasmid from B20. Lane 4: X 
Hind i n digested marker. Lane 5: Intact pBluescript SK+. 
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5.3.3 Nucleotide Sequence Analysis 
A l l , A12, A13, B13, B15 and B20 were selected for DNA sequencing. 
The nucleotide sequences of Fragments A and B were shown in Figure 5.6 
and 5.7 respectively. Their sequences were compared with the reported 
GHR cDNA sequences by the computer program DNASIS. They share 
very low homology to the reported GHR cDNA sequence. The result of the 
nucleotide homology comparison between the two fragments and the 
reported GHR cDNA sequences was summarized in Table 5.2. 
5’ 1 CTGGTCAAGG CACAAGAGCC CTTGCATGTG CGTACGTTGA TGTCAATATC AACCTCAAGC 
61 CGCTGTATTA CAATGACTTG ATCTTTGACC TGCGACTTCA GAGCGTCTAG CAACCGGAGT 
121 TGACGATCAA TTTTAATCTT GATATCAGTA ATCCTTTGTC TCAGCTGTTC AGCCAAGGTG 
181 GCGTACCTGT TATCATTTCC GGCGCTAGAA GTCAATCGAT CTCTTAGGTA AGTGTAAGTG 
241 GTTTTGACAC TGATCAGCGG AGCGATACAG TTTCCGGCCC TCGTCCAGAA GACGACGAAT 
3 01 CCTCTCAATC TTCTTGAGGA TATCATGGTC AGCTTTGTCC ATGAGGCCTT GAATTCGGCA 
361 GCCGGATGGA CATTTGGTTC CCCAGTCTTC ATCTGTACAC ATAGGCCATT CTTTGGTCTT 
421 ACAGGTGTCT TGTGCCTTGA CCAG 3’ 
Figure 5.6. The nucleotide sequence of Fragment A. The PCR primers were underlined. 
5, 1 AGGTATGGAT CTTCGGCCAT ATGCAAAACT CATCGAAGAA AGAAAGCCTG AATGGCTTAT 
61 TATTGAAAAT GTTCCCGGAC TGCTCAACAG CCACATGGAC AAGACTTCAA AGTTGTCATC 
121 GATACGTTGG TCGAATTCGG GTATGGCGTT TCGTGGAGAG TATTGGATGC AAAATACTTG 
181 GAACACCCCA GCGTAGAAGA AGAGCGCACA TTGTCGCAAG TCTTGGAGAC ATTTTAATCG 
241 GATATCCGGA ATCAGTAGCT GTCATGATCA TGCTAGCTGA TAGCTAGCTA GTCGATCGTC 
301 CATGATAGTC TAGCTTTAGT GGGGGCATGT AATCGATAGC TAGCTAGTAG CTAGCTCCGT 
3 61 ACTGATCGAT CGATGCTAGT CGATCTAGTC GATCGTAGTT CTAGCTAGAA TGATCCATGA 
421 CTAGCTGATC GCGATCGATC TTGATCGATG CTAGTCGATG GATTTGATCG ATTGCTAGTA 
I 
481 GATGAGTAGA TCGATGTAGT CGATGCTAGT ACTATGATCA GAAAGGATG 3 ‘ 
Figure 5.7. The nucleotide sequ«ice ofFragmait B. The PCR primers were underlined. 
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Fragment A (444 bp) Fragment B (529 bp) 
Organism Number of Percentage of Number of Percentage of 
overlapping nucleotide overlapping nucleotide 
nucleotides homology nucleotides homology 
Pigeon 58 42.8% 63 48.9% 
Chicken 60 44.1% 60 50.2% 
Human 66 45.9% 58 46.8% 
Mouse 52 47.8% N.O. N.H. 
Porcine 72 45.3% N.O. N.H. 
Rat 58 52.3% 54 60.3% 
Sheep 52 45.9% 62 49.8% 
Key : N.O. : no overlapping region 
N.H. : no homology 
Table 5.2. The result of nucleotide homology comparison betweoi Fragments A and B and the 
rq)orted GHR cDNA sequmces by the computer program DNASIS. 
The nucleotide sequences of Fragment A and B were also compared with 
the sequences in Genebank and the result was summarized in Table 5.3 
and 5.4 respectively. 
I 
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Sequences Number of overlapping Percentage of 
nucelotides nucleotide homology 
Chicken alpha- 439 57.6% 
fibrinogen mRNA, 3' 
end 
Human fibrinogen A- 430 51.6% 
alpha-chain mRNA 
Human HLA-SB(DP) 341 48.4% 
alpha gene 
Sea urchin actin gene 37.1% 
Rat alpha-fibrinogen 385 46.0% 
gene 
Petromyzon marinus 4 3 7 4 8 . 1 % 
fibrinogen alpha chain 
Human vitamin D 369 46.1% 
receptor mRNA 
Human fibroblast 443 47% 
interferon 
Human cyclin protein 363 49.6% 
gene 
Table 5.3. The result of nucleotide homology comparison betweai Fragments A and the 
sequaices in Goiebank by the computer program DNASIS. 
i 
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Sequences Number of overlapping Percentage of 
nucelotides nucleotide homology 
Caenorhabditis elegans 386 47.2% 
elongation factor 2-like 
gene 
Human hnRNP core 45.6 536% 
protein Al 
Drosophila 2 8 0 4 7 . 5 % 
melanogaster Shabll 
protein mRNA 
Human ADP- 158 46.2% 
ribosylation factor 1 
Table 5.4. The result of nucleotide homology comparison betweai Fragm«its B and the 
sequences in Gaiebank by the computer program DNASIS. 
5.3.4 Northern Analysis 
The total RNA and mRNA of Dace liver were fractionated by 
formaldehyde / agarose gel (Figure 5.8) and then transferred to Hybon-N 
nylon membrane. The RNA was hybridized with [a32p]dCTP labeled 
chicken GHR cDNA overnight at SO^C, 6X SSC. The hybridized 
membrane was washed twice at 50OC, 2X SSC and exposed overnight to 
X-ray film. The autoradiograph was shown in Figure 5.9. It was found the 
Dace RNA could not hybridized with the chicken GHR cDNA probe at 
50OC, 2X SSC. 
117 
10 9 8 7 6 5 4 3 2 1 
i M H 
I 
Figure 5.8. Formalddiyde / agarose gel analysis of RNA. Lane 1: 5 |ag of Dace liver mRNA. 
Lane 2: 2 fig Dace liver total RNA. Lane 3: 4 fig of Dace liver total RNA. Lane 4: 25 |Lig Dace 
liver total RNA. Lane 5: 20 |Lig Dace liver total RNA. Lane 6: RNA marker. Lane 7: 2 |ag Dace 
muscle total RNA. Lane 8: 4 |ag of Dace muscle total RNA. Lane 9: 8 ^g Dace muscle total 
RNA. Lane 10: 9 |ig chickoi brain mRNA. 
10 9 8 7 6 
Figure 5.9. Autoradiogtraph of the result of Northern analysis using [a^^PldCTP labeled fuU 
laigth chicken GHR cDNA as probe. Lane 1: 5 |Lig of Dace liver mRNA. Lane 2: 2 � Dace 
liver total RNA. Lane 3: 4 of Dace liver total RNA. Lane 4: 25 � Dace liver total RNA. 
Lane 5: 20 � Dace liver total RNA. Lane 6: RNA marker. Lane 7: 2 ^ Date muscle total 
RNA. Lane 8: 4 |ag of Dace muscle total RNA. Lane 9: 8 � Dace muscle total RNA. Lane 10: 
9 chickQi brain mRNA. 
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5.4 Discussion 
The present study aims at cloning the Dace GHR cDNA. In the employed 
strategy, four pairs of PCR primers were designed order to amplify 
fragments of Dace GHR cDNA from the first strand cDNA pool The 
primers were designed from the conserved regions of the reported GHR 
cDNA sequences because it is believed that these conserved regions might 
also be present in Dace GHR. The chicken GHR cDNA was also cloned 
using this approach (Bumside et al； 1991). 
Two fragments were amplified from the Dace first strand cDNA using 
primers GHRpl and GHRp2, and primers GHRp5 and GHRp6. The sizes 
of these two fragments were similar to the expected sizes. Therefore these 
two fragments were subcloned. The nucleotide sequence of the fragments 
were determined by dideoxy-sequencing. Unfortunately, it was found that 
the nucleotide sequences of the two fragments only bear a low homology to 
the reported GHR cDNA sequences. Only a small portion of these two 
fragments can align with the reported sequences and the homology of the 
aligned regions are only about 50%.It is therefore doubtful that these 
fragments represent portions of the Dace GHR cDNA sequence. 
In another approach chicken GHR cDNA was labeled and hybridized with 
Dace liver RNA in order to see whether this heterologous probe can 
hybridize with Dace GHR mRNA. If a positive signal is obtained, this 
heterologous probe can be used in fish liver library screening. The clones 
containing rabbit, mouse, rat and sheep GHR were in fact screened out 
using heterologous probes (Leung et al., 1986; Mathews et al., 1989; 
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Smith et al., 1989; Adams et aL, 1990). In our experiment the Dace RNA 
immobilized membrane was hybridized overnight with chicken GHR 
cDNA at 50OC, 6X SSC and was then washed at 50OC, 2X SSC. The 
conditions used were calculated according to Sambrook et al (1989). The 
hybridization temperature chosen was 50OC, by assuming that the chicken 
GHR cDNA can perfectly match with the Dace GHR RNA. Then the Tm 
of the chicken GHR cDNA and Dace GHR RNA hybrid is 90^0, 
calculated by the following equation : 
Tm = 69,3 + 0.41(%G+C) 
assuming (%G+C) is 50% 
The Tm of a double-stranded nucleic acid hybrid decreases by 1 � � w i t h 
every 1% decrease in homology. If there is 30% mismatch between 
chicken & Dace GHR gene, the Tm value should be 60OC. 
Washing was performed at SO^C, 2X SSC. The decreases in ionic strength 
will lower the Tm. The relationship is governed by the following equation: 
Change in Tm � 18.5 x log (hybridization ionic strength / washing 
ionic strength) 
Ionic strength is expressed as strength of SSC. 
Therefore washing with 2X SSC solution lowers the Tm from 6 0 � � t o 
51.20C. For 30% mismatch, the probe will not be washed out. 
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The result of the Northern analysis is shown in Figure 5.9. It was found 
that either Dace total RNA or mRNA hybridized minimally with the 
chicken GHR cDNA probe after the membrane was washed at 50OC，2X 
SSC. From the result we can conclude that there are more�than 30% 
mismatch between chicken & Dace GHR cDNA. Therefore it is conceded 
that screening using heterologous probe is perhaps not applicable in this 
study. 
The employed strategies are based on an assumption that there is a certain 
degree of nucleotide sequence homology between the Dace GHR to the 
reported GHRs. This strategy is not valid if their homology is very low. 
Although the present strategy failed, there exists several other ways to 
achieve our goal. Antibody screening is a common method of library 
screening. It is known that the function of a protein can be determined by 
its three dimensional structure. As in the case of hemoglobin and 
myoglobin the nucleotide and amino acid sequence are rather different but 
their function and three-dimensional structure are quite similar (Stryer, 
1988). Although the nucleotide sequence homology between Dace GHR 
and the reported GHRs, as predicted by our result, is very low, their three 
dimensional structure may still be very similar. Therefore they might share 
some common epitopes, antibodies against reported GHRs can serve as 
probes to screen the Dace cDNA library. 
Protein purification is another approach. The Dace liver GHR can be 
purified by affinity chromatography using a solid phase linked with GH. 
Partial protein sequencing could allow the design of a nucleotide probe 
which can be used to screen the Dace cDNA library. 
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In addition to library screening, cloning by expression in mammalian cells 
can be a useful tool in the identification and isolation of Dace GHR cDNA. 
Expression cloning has been successfully applied to cell surface receptors 
(Sambrook et aL, 1989). A Dace liver cDNA library , in mammalian 
expression vectors, can be transfected into mammalian cells such as 
COS 7, a GHR nonresponsive cell line which is frequently employed in 
GHR research. The cells expressing Dace GHR can be identified through 






Chapter 6 General Discussion 
It was found that chicken hepatic GHR mRNA level drastically decrease 
just before hatching. The sudden decrease of the hepatic GHR level may 
be due to the high circulating GH concentration at the time of hatching 
(Harvey et al., 1979; Vanderpooten et aL, 1991). The elevation of 
circulating GH before hatching appears to have no direct effect on the 
brain GHR mRNA level. Lawrence et al (1982) have demonstrated the 
presence of immunoreactive GH in rat brain. Moreover GH mRNA has 
been identified in rat brain (Gossard et al., 1987). Therefore it is believed 
that in addition to somatotrophs of the pituitary gland, other cell type(s) in 
brain may secrete GH as well. It is well known that brain comprises a 
mixed population of cells such as astrocytes, neuronal cells, 
oligodendrocytes, etc. Therefore identification of the cell type(s) which 
can secrete GH will provide more information on GH and GHR interaction 
in brain. 
In addition to the ontogeny study, we have also attempted to prokaryotic 
express the chicken GHR cDNA in a bacterial system. Unfortunately, the 
receptor protein could not be expressed.The reason(s) for the failed 
expression is still unknown but may be due to gene expression 
interference, instability of the receptor mRNA or degradation of the 
receptor protein etc. In this context, it is worthy to note that the 
extracellular domain of human GHR has been successfully expressed in 
the baculovirus system (Ota et al., 1991). This system may also be useful 
for the expression of chicken GHR. The expressed chicken GHR can be 
used for the generation of antibodies against GHR. These antibodies may 
be useful in cloning other vertebrate GHR cDNAs, including fish. 
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Pigeon GHR cDNA was successfully cloned by PCR techniques. In the 
literature, all the reported GHR cDNAs were cloned by standard cDNA 
library screening, with the only exception of porcine GHR cDNA. PCR 
cloning has several advantages over library screening method. First of all, 
it is not necessary to construct a cDNA library. The quality of the library 
will strongly affect the efficiency of screening. Second, amplification of 
the target gene from the first strand cDNA pool is much faster than 
screening the cDNA library. Third, the use of radioactive isotopes is 
minimized. 
The signal transduction mechanism of GH is still unclear. In addition, the 
signal transduction of GH in birds and in mammals might be very different. 
Different physiological responses were observed after GH administration 
in chicken as compared to those in mammals. Therefore the pigeon GHR 
cDNA successfully obtained by us can be used as a tool for establishing an 
in vitro system to study the mechanism of GH signaling in birds. 
Transfection of the receptor cDNA into cultured cell can provide 
information about the physiological significance of GH in these cells. 
Isoforms of GHR were identified in several species of animals (Smith & 
Talamantes, 1987; Glimm et al” 1990), so the cDNA can be used as a 
probe to detect whether GHR isoform(s) exist in pigeon as well. 
Cloning of Dace GHR cDNA was also attempted. Both PCR by GHR 
conserved primers and heterologous probe screening failed. 5*rom the 
results we predict that fish GHR is evolutionarily more distant from the 
known GHRs, therefore their DNA sequence are not highly conserved. We 
might have to resort to other cloning approaches. As mentioned before 
antibody screening may be useful. Expression cloning is also frequently 
employed for cloning cell surface receptor. Our preliminary experiment 
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showed that the chicken GHR cDNA can be successfully expressed in an 
eukaryotic system (human kidney 293 cells) exhibiting GH binding activity 
(personal communication, data not shown). This result indicates the 
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Figure Al. pBluescript SK +/- vector and the multiple cloning site sequoice. 
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Figure A2. pET 3a vector and the mutiple cloning site sequoice. 
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